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GENERAL INTRODUCTION 
Thesis Organization 
This thesis is to partly fulfill the requirements for a Masters of Science degree. It 
consists of two papers. The first one deals with the effects of dietary sources of CLA on 
availability of CLA and other long-chain fatty acids for absorption from the intestine of 
sheep. The second one deals with the effect of dietary source of CLA on CLA content of 
milk. Each paper is complete by itself, with an abstract, introduction, materials and 
methods, results and discussion, and bibliography. An overall literature review precedes 
the first paper, and a general discussion follows the second paper. A final bibliography 
contains references included in the literature review and the general discussion. 
Literature Review 
Conjugated linoleic acid (CLA), a derivative of linoleic acid, has been of 
considerable interest to nutritional scientists during the past few years because of its 
unique physiological properties. On the basis of a series of experiments focused on 
ruminal digestion of dietary fats during the late 1950s and 1960s, CLA was discovered as 
an intermediate in the biohydrogenation pathways of several polyunsaturated fatty acids 
in the rumen by rumen microbes (Kepler et al., 1966). Several studies have since then 
been conducted to elucidate the different physiological effects of CLA and its 
mechanisms of action and to search for efficient ways to increase CLA concentrations in 
animal products. 
Chemistry of CLA 
CLA refers to a mixture of positional and geometric isomers of linoleic acid that 
has double bonds at either the 7 and 9, 8 and 10, 9 and 11, 10 and 12, 11 and 13, or 12 
and 14 positions in the cis or trans configuration. Nineteen different isomers of CLA have 
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been identified (t7, c9-18:2; c7, c9-l8:2; t7, t9-18:2; t8, cl0-18:2; c8, cl0-18:2; t8, tl0-
18:2; c9, tll-18:2; t9, cll-18:2; c9, cll-18:2; t9, tll-18:2; clO, t12-18:2; tl0, cl2-18:2; 
clO, c12-18:2; tl0, t12-18:2; ell, c13-18:2; tll, t13-18:2; c12, t14-18:2; c12, c14-18:2; 
t12, t14-18:2) (Sehat et al., 1998). It is thought that some of these isomers are not 
biologically important. Rather, c9, tll-CLA and/or t9, cll-CLA is (are) the most 
biologically active. The c9, tll- and t9, cll-CLA are preferentially incorporated into 
tissue phospholipids of the forestomach (Ha et al., 1990), liver, and mammary tumor (Ip 
et al., 1991). Those two isomers are found in relatively higher proportions in uncooked 
animal-derived foods (Ha et al., 1990) and in human tissues (Harrison et al., 1985; 
Iversen et al., 1984; Smith et al., 1991), whereas the other isomers (e.g. t9, tll-18:2; tl0, 
c12-18:2), dominate in cooked foods. Furthermore, the stereospecific, phospholipid-
dependent c9, tll-reductase found in ruminal bacteria is associated with the enzymatic 
hydrogenation of CLA in ruminants. 
Biosynthesis of CLA 
Synthesis of CLA requires the presence of free linoleic acid (the substrate), a free 
radical-generating species, and proteins rich in sulfur residues (Chin et al., 1992). Heat 
treatment (Ha et al., 1987), free-radical-type oxidation of linoleic acid (Cawood et al., 
1983), and microbial enzymatic reactions (through oxidative pathways and enzymatic 
isomerization) involving linoleic or linolenic acids (Gurr, 1987; Viviani, 1970; Chin et 
al., 1992) are thought to be major contributors to CLA formation in foods. 
Biohydrogenation in the rumen. Ruminal biohydrogenation of unsaturated fatty 
acids is very efficient, and it resuJts in a high percentage of the unsaturated 18-carbon 
fatty acids being reduced to stearic acid, which decreases the percentage of trans-18:1 
acids (Jilg et al., 1988). The most fundamental of those biohydrogenation pathways of 
various fatty acids in the rumen by rumen microbes is the conversion of linoleic acid to 
oleic acid by the bacterium Butyrivibrio fibrisolvens (Polan et al., 1964). This conversion 
occurs as a two-step reaction, with the formation of CLA as an intermediate (Kepler et 
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al., 1966). Linoleate isomerase, which facilitates the formation of CLA, produces only 
the c9, tll- isomer of CLA, which is the primary isomer found in ruminant meat and milk 
(Kepler and Tove, 1967; Kepler et al., 1970, 1971). 
Studies have been performed to clarify the mechanism of conversion of CLA to 
oleic acid (Rosenfeld and Tove, 1971). The production of c9, tll-18:2 is the first step in 
the biohydrogenation pathway of linoleic acid. A study by Noble et al. (1974) showed 
that ruminal microorganisms from sheep produce tll-18:1 together with c9, tll-18:2. 
The strong linear correlation between concentrations of c9, tll-18:2 and t11-18:1 
suggested that the first two steps in the biohydrogenation reaction (from 18 :2 via c9, t11-
18:2 to tll-18:1 ) were not rate-limiting. After the formation of the trans-11 bond by 
linoleate isomerease, the hydrogenation of the cis-9 bond took place, and tll-18:1 was 
formed (Kepler et al., 1971). These two reactions were catalyzed by enzymes from one of 
the distinct populations of microorganisms capable of hydrogenation in the rumen, e.g., 
Butyrivibrio fibrisolvens (Kepler et al., 1967). But the rate-limiting step in the complete 
biohydrogenation of linoleic acid to stearic acid, the step of tll-18:1 to 18:0, was not 
related to these bacteria. The increase in tll-18:1 concentration was observed after 
feeding cows with high-oleic sunflower oil; however, trans-isomers are not thought to be 
intermediates for oleic acid hydrogenation, and the resulting high concentration of tl 1-
18: 1 was considered to be a result of the large amount of dietary conjugated diene 
available for biohydrogenation (Kalscheur et al., 1997). Trans-18:1, either of dietary 
origin or from incomplete biohydrogenation of unsaturated fatty acids, seems to depress 
bovine milk fat percentage (Wonsil et al., 1994). Corl et al. (1998) suggested a possible 
synthesis of CLA isomers in the mammary gland of cows from tll-18:1 by the ~-9 
desaturase. 
Formation in nonruminants. Studies have been conducted on CLA synthesis in 
nonruminants by feeding linoleic acid to conventional and germ-free rats (Chin et al., 
1994). It was shown that tissue concentrations of CLA were greater in conventional rats 
fed free linoleic acid than in germ-free rats, whereas CLA concentrations in the tissues of 
germ-free rats were not affected by diet. Therefore, CLA found in the tissues of 
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nonruminants is not only a consequence of dietary intake but also partly the result of the 
conversion of free linoleic acid (but not linoleic acid esterified in triacylglycerol) to the 
c9, tl 1-CLA isomer by intestinal bacterial flora. CLA was found in triacylglycerols of the 
carcass when trans-vaccenic acid was fed to mice, suggesting that desaturation of the tl 1-
18: 1 at the ~-9 position occurred in the adipose tissue (Santora et al., 2000). Moreover, 
dietary trans-vaccenic acid increases the CLA concentration in human serum by way of 
its desaturation in the human tissue (Salminen et al., 1998). 
Unique biological properties of CLA 
CLA research has caused great attention because of its multiple positive effects on 
human health. These beneficial effects now will be described. 
Anti-carcinogenic. Like other polyunsaturated fatty acids (PUFA), CLA may 
modulate carcinogenesis by affecting individual stages of cancer development, such as 
initiation, promotion, progression, and/or regression. The anticarcinogenic property of 
CLA was first identified in the mouse skin multistage carcinogenesis model. CLA was 
found to inhibit 7,12-dimethlbenz[a] anthracene (DMBA)-induced mouse epidermal 
tumors (Ha et al., 1987) . Because CLA was shown to be a potent inhibitor of DMBA 
conversion to its ultimate carcinogenic form via cytochrome P450, it was suggested that 
CLA inhibits skin carcinogenesis by chemical modification of the metabolism of the 
carcinogen. Additionally, synthetic mixtures of CLA inhibited benzo[a]pyrene-induced 
mouse forestomach neoplasia (Ha et al., 1990) and rat mammary tumorigenesis (Ip et al., 
1991). Severe combined immunodeficient (SCIO) mice inoculated with DU-145 human 
prostatic carcinoma cells displayed smaller local tumors and a marked decrease in lung 
metastases when fed a diet supplemented with CLA versus mice fed the control diet 
(Cesano et al., 1998). Also, CLA suppressed growth of human breast adenocarcinoma 
cells in SCIO mice (Visonneau et al., 1997). In cell culture studies, physiological 
concentrations of CLA inhibited the proliferation of human malignant melanoma, 
colorectal, and breast cancer cells (Shultz et al., 1992) and of three lung adenocarcinoma 
cell lines (Schonberg and Krokan, 1995). Morever, CLA inhibited proliferation and 
induced apoptosis of normal rat mammary epithelial cells in primary culture (Ip et al., 
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1999). Both a decrease in cell numbers and an increase in lipid peroxidation were 
observed when human MCF-7 and SW 480 cancer cells were exposed to CLA in culture 
(O'Shea et al., 1999). Ip et al. (1999) found that butterfat rich in CLA had biological 
activities similar to those of a mixture of free acid CLA isomers. Feeding butterfat rich in 
CLA to rats during the time of pubescent mammary gland development decreased the 
size of the terminal end bud population, which are target cells for mammary chemical 
carcinogenesis; again, CLA was shown to inhibit mammary tumor yield (Ip et al., 1999). 
Because CLA is readily incorporated into cell membrane phospholipids, it may 
inhibit carcinogenesis by modulating several cellular events mediated by the lipid milieu 
of the plasma membrane. Several mechanisms by which CLA could influence 
carcinogenesis were proposed, which vary for different anatomical sites, age, duration of 
exposure, and stage of carcinogenesis. For example, CLA may act by antioxidant 
mechanisms (Ha et al., 1990; Ip et al., 1991). CLA could prevent the lipid peroxidation 
and subsequent damage by hydroxyl radicals to those membrane sites critically involved 
in the induction of different pathological conditions, such as initiation and promotion of 
carcinogenesis (Ha et al., 1990). Also, CLA may act by prooxidant cytotoxicity 
(Schonberg and Krokan, 1995; O'Shea et al., 1999; Basu et al., 2000). There was a dose-
dependent decrease in human MCF-7 and SW480 cancer cell numbers and an increase in 
lipid peroxidation when both cell lines were incubated with CLA, suggesting that CLA-
induced antioxidant enzymes failed to protect those cancer cells from cytotoxic lipid 
products (O'Shea et al., 1999). In an in vivo study, CLA supplementation of a human diet 
resulted in significant increases in urinary concentration of 8-iso-PGF and 15-keto-
dihydro-PGF, indicating that CLA could induce both nonenzymatic and enzymatic lipid 
peroxidation in vivo (Basu et al., 2000). Another mechanism has been proposed; CLA 
may act by inhibition of nucleotide synthesis (Shultz et al., 1992; Ip et al., 1999). Human 
MCF-7 breast cancer cells supplemented with CLA incorporated significantly less uridine 
and thymidine than did control cultures (Shultz et al., 1992). CLA was found to inhibit 
growth of normal rat mammary epithelial cell organoids in primary culture both by a 
decrease in DNA synthesis and a stimulation of apoptosis; thus, CLA may prevent breast 
cancer by inhibiting outgrowth of initiated mammary epithelial cell organoids (Ip et al., 
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1999). Ip and colleagues suggested that CLA may act by inhibiting cell proliferative 
activity (Ip et al., 1994; Ip et al., 1999). Ip et al. (1994) and Thompson et al. (1997) found 
that CLA had a direct modulating effect on susceptibility of the target organ to neoplastic 
transformation and decreased the proliferative activity of the lobuloalveolar structures of 
the mammary gland of rats given DMBA and methylnitrosourea. Another suggestion is 
that CLA may act by modulation of eicosanoid metabolism (Belury and Kempa-Steczko, 
1997; Banni et al., 1999). Feeding a diet with 1 % CLA resulted in a significant decrease 
in arachidonic acid (20:4), which is the substrate for the cyclooxygenase and 
lipoxygenase pathways of eicosanoid biosynthesis, in rat mammary tissue. Ip et al. 
(1995) found that the anticancer activities of CLA as the free fatty acid and in 
triacylglycerol are essentially identical and that anticancer activity is related to the 
duration of intake of supplemental CLA, suggesting the involvement of active 
metabolites of CLA to suppress neoplastic progression. 
Anti-atherogenic. Coronary heart (#sease (CHD) is mostly the result of 
obstruction of coronary vessels by atherosclerosis, thrombosis, or both (Ulbricht and 
Southgate, 1991). A popular hypothesis about the causes of atherosclerosis is free radical 
damage to lipids in circulating low-density lipoprotein (LDL). Seven dietary factors have 
been recognized to be involved in the process. Two promoters of CHD development are 
blood cholesterol-raising saturated fatty acids (SFA) and thrombogenic SFA. Five 
protective factors are PUFA of the n-6 Oinoleic) acid series, PUFA of the n-3 (linolenic) 
acid series, monounsaturated fatty acids (MUFA), dietary fiber, and antioxidants. How 
those factors work together is not clear, though intuitively they would be expected to 
work in a complex but integrated way. Because fatty acids are closely related to risk of 
CHD, several indices have been worked out to take into account the damaging and 
protective effects of those fatty acids and to set criteria for diet comparison. 
Many epidemiological studies have illustrated a positive correlation between 
serum cholesterol concentrations and incidences of CHD. High concentrations of 
cholesterol, especially of LDL-cholesterol, seem to have a positive effect on development 
of atheroma (Mangiapane and Salter, 1999). Oxidized LDL is taken up by macrophages 
and deposited in the plaque, whereas inhibition of LDL oxidation slows the progression 
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of atherosclerotic lesi0ns. Yet, the different SFA ate not equally likely to cause 
hypercholesterolaemia. The putative atherogenic SFA are shown to be 12:0 (lauric), 14:0 
(myristic), and 16:0 (palmitic) but not 18:0 (stearic) (Bonanome and Grundy, 1988; 
Hegsted, et al., 1965). 
Anti-atherogenic ef,fects of CLA have been reported in experiments with hamsters 
(Nicolosi et al., 1997; Gavino et al., 2000) and rabbits (Lee et al., 1994). CLA-fed 
hamsters had significantly lower plasma total cholesterol, LDL-cholesterol and 
triacylglycerol concentrations, as well as a significant decrease in aortic streak formation 
(Nicolosi et al., 1993). Gavino et al. (2000) further found that c9, tll-CLA did not 
produce the same effect of lowing plasma cholesterol as the CLA isomer mixture under 
short-term feeding for 6 weeks. When rabbits were fed the atherogenic diet first for 
several months and then fed a diet containing CLA, the severity of atherosclerotic lesions 
developing in the aorta of the rabbits was decreased when compared with those of the 
control group. And blood total cholesterol, LDL-cholesterol, and triacylglycerol were 
significantly decreased in the rabbits fed supplemental CLA for 12 weeks (Lee et al., 
1994). Evidently, CLA prevents development of heart disease by slowing the 
accumulation of lipids in the arteries, which causes atherosclerosis. On the basis of 
results of Lee et al. (1994), changes in serum lipids may not be a good measure of the 
anti-atherogenic effects of CLA and increased concentration of serum cholesterol is not 
adequate to explain increased risk of CHD. However, LDL is still considered to be the 
most atherogenic lipoprotein and its atherogenic potential lies in the number of more 
dense LDL particles (Griffin, 1999). In a study by Munday et al. (1999), addition of CLA 
to the atherogenic diet of mice led to a significantly higher serum high density lipoprotein 
(HDL)-cholesterol to total cholesterol ratio and a significantly lower serum 
triacylglycerol concentration than in control mice, which had linoleic acid added at 
similar amounts to the diet. The CLA supplementation, however, increased the 
development of aortic fatty streaks and thus provided no conclusive evidence to support 
the anti-atherogenic property of CLA that had been suggested in research with hamsters 
and rabbits. 
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CLA also may possess antithrombotic properties as suggested by Truitt et al. 
(1999). They found that c9, tll- and tl0, c12-CLA inhibited arachidonic acid- and 
collagen-induced platelet aggregation with either thrombin or calcium ionophore A23187 
as aggregating agents, whereas the nonconjugated linoleic acid was about 50% less 
potent as an inhibitor for those aggregating agents. The two CLA isomers were found to 
inhibit formation of proaggregatory cyclooxygenase-catalyzed product thromboxane A2, 
and to have no effect on production of the platelet lipoxygenase metabolites. 
Though closely related, the process of thrombosis and atherosclerosis are different 
(Parthasarathy et al., 1990). Three thrombogenic fatty acids, 14:0, 16:0, and 18:0 are 
highly correlated with greater platelet aggregation in rats (McGregor et al., 1980). Then-
6 series PUFA, especially the cis-PUFA, inhibit platelet aggregation, and their 
antithrombosis effect is suggested to be related to an increase in fluidity of platelet 
membranes (MacIntyre et al., 1984). 
It has long been known that increasing dietary PUF A of the n-6 series decreases 
serum cholesterol concentrations in humans and other mammals (Ulbricht and Southgate, 
1991). Yet, it also was shown that diets rich in PUFA depress HDL, a protective agent 
against CHD, as well as LDL (Shepherd et al., 1978; Mattson and Grundy, 1985; Grundy, 
1986). Thus, it is thought that a modest increase in the intake of n-6 fatty acid is 
appropriate for lessening the rate of atherogenesis. 
In contrast to the n-6 series PUFA, the n-3 series PUFA has a principal effect of 
being antithrombogenic. High amounts of n-3 PUFA facilitate production of the 
prostanoid prostacyclin 13 which is a potent inhibitor of platelet aggregation, whereas 
eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) act by inhibiting 
c_onversion of arachidonic acid to the prostanoid thromboxane A2 by platelets (Rao, et al., 
1983). The n-3 PUFA also have antiatherogenic effects by decreasing the rate of 
synthesis of apolipoprotein B, which leads to a decrease in very low density lipoprotein 
(VLDL) and finally to a depression of LDL, an increase of HDL, and a decline of plasma 
triacylglycerol (Saynor and Gillot, 1988). 
Diets rich in MUF A lower serum cholesterol of humans without lowering HDL 
(Mattson and Grundy, 1985; Grundy, 1986; Mensink and Katan, 1989; Wardlaw et al., 
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1990). And, oleic acid inhibits platelet aggregation (MacIntyre et al., 1984; Sinclair, 
1984). 
Besides the fatty acid factor, it was found that men consuming larger amount of 
bread and other cereal products had a low CHD rate; the cholesterol lowering effect of 
fiber contained therein was hypothesized (Kannel et al., 1987). However, because of the 
confounding change associated with other dietary constituents and the fiber content of the 
diet, a consistent proof of the fiber hypothesis has not been worked out yet. 
Antioxidants, especially vitamins C and E and carotenoids, also are suggested to 
be antiatherosclerotic by protecting LDL-cholesterol against oxidation. Vitamin E was 
shown to decrease platelet aggregability. Important effects of antioxidants in the 
regulation of platelet function were suggested by the strong association between low 
serum selenium and platelet aggregability (Salonen, 1989). 
The ratio of PUFA to SFA (PIS) in the diet often has been used to estimate 
atherogenicity of the diet. But because only three of the major SFA are actually 
hypercholesterolemic and their effects are not equal, a more suitable index was suggested 
instead (Ulbricht and Southgate, 1991). The index is expressed as follows: 
' " "' aS+bS +cS 
' dP+eM+fM 
, " "' where S =12:0, S =14:0, S =16:0; P=sum of n-6 and n-3 PUFA; M=18:1; 
' M = sum of other MUF A. 
Because myristic acid was thought to be most atherogenic, with about four times 
the cholesterol-raising potential of palmitic acid (Hegsted et al., 1965), bis set to 4. The 
coefficients a-fare empirical constants and a-f, excluding b, are set provisionally to unity 
until firm evidence for other values becomes established. 
Ulbricht and Southgate (1991) also proposed an index of thrombogenicity (IT) for 
dietary fatty acids. The proposed ratio for IT is: 
, n-3 
nM+oM +p(n-6)+q(n-3)+--
n-6 
where iv =sum of 14:0, 16:0, and 18:0; n-6=n-6 PUFA; n-3=n-3 PUFA; 
' M=l8:l; M =sum of other MUFA. 
The coefficients m, n, o, p, and q are empirical constants with m set to unity and 
n, o, p set to 0.5 because MUFA and n-6 PUFA are less antiatherogenic than n-3 PUFA; 
likewise, q was set to 3. 
Anti-obesity. Feeding diets.supplemented with CLA to mice increased lean body 
mass relative to that of controls (Park et al., 1997). A study by West et al. (1998) showed 
that CLA decreased body fat of mice by decreasing energy intake, increasing metabolic 
rate, and shifting the nocturnal fuel mix. In contrast, Delany et al. (1999) found that 
feeding CLA to mice produced a marked decrease in fat accumulation without major 
effects on food intake. Pigs fed CLA deposited less subcutaneous adipose tissue and 
gained more lean tissue than did pigs fed diets rich in linoleic acid (Dugan et al., 1997). 
Pertaining to the mechanism of this anti-obesity effect, dietary CLA increased the 
activity of carnitine palmitoyltransferase, the rate-limiting enzyme for fatty acid beta-
oxidation, and hormone-sensitive lipase, which hydrolyzes lipids in adipocytes for release 
of fatty acids to the blood (Park et al., 1997). Brodie et al. (1999) found that CLA 
inhibited differentiation of pre- and post- confluent 3T3-Ll preadipocytes and cell 
proliferation of preconfluent cells. Moreover, in cultured 3T3-Ll adipocytes, CLA 
treatment significantly decreased heparin-releasable lipoprotein lipase activity and the 
intracellular concentrations of triacylglycerol and glycerol but significantly increased free 
glycerol in the culture medium. Therefore, the effects of CLA on body composition seem 
to be partly the result of decreased triacylglycerol deposition and increased lipolysis in 
adipocytes, which are possibly coupled with enhanced fatty acid oxidation in both muscle 
cells and adipocytes. 
Moreover, it was the tlO, cl2-CLA isomer that decreased lipoprotein lipase 
activity, intracellular triacylglycerol, and glycerol and enhanced glycerol release into the 
medium of cultured 3T3-Ll adipocytes (Park et al., 1999); the c9, tll-CLA isomer had 
no effect on those biochemical activities. The effect of the tlO, c12-CLA isomer on body 
composition change also was suggested by the findings that dietary tlO, cl2- isomer was 
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cleared significantly faster than c9, tll- isomer from skeletal muscle of mice fed a diet 
supplemented with CLA (Park et al., 1999). 
Immune-modulatory. The effect of CLA on immune function has been 
examined in rats. Concentrations of immunoglobulin A (IgA), IgG, and IgM in the spleen 
increased, whereas those of IgE decreased significantly in rats fed a 1.0% CLA diet 
(Sugano et al., 1998). A food allergy reaction is initiated by the production of allergen-
specific IgE, whereas IgA and IgG serve as antiallergenic factors by interfering with the 
intestinal absorption of allergen and competing with binding of allergen to receptors on 
surfaces of target cells (Metcalfe, 1991). Because of these propeties of specific 
immunoglobulins, CLA mitigates the food-induced allergic reaction. Also, CLA 
stimulates the immune system as shown by increased concentration of CD8+ -specific T 
cells in chickens (Devoney et al., 1997). Membrane-bound CLA and its desaturated (by 
Ll-6 desaturase) or elongated products may compete with other PUF As for 
phospholipases, cyclooxygenase, and lipoxygenases and consequently decrease the 
production of eicosanoids, which leads to decreased prostaglandin production (Reeves 
and Todd, 1996). 
Feeding diets containing 0.3% and 0.9% CLA to mice resulted in lymphocyte 
proliferation in phythoemagglutinin-induced but not in concanavalinA- or 
lipopolysaccharide-stimulated cultures (Wong et al., 1997). CLA also was shown to 
stimulate mitogen-induced lymphocyte proliferation, lymphocyte cytotoxic activity, and 
macrophage bactericidal activity, but it inhibited interleukin-2 production by 
lymphocytes and suppressed the phagocytic activity of macrophages (Chew et al., 1997). 
Beta-carotene interacts additively with CLA to enhance lymphocyte cytotoxicity and 
spontaneous lymphocyte proliferation, and the former is shown to negate the inhibitory 
action of CLA on the phagocytic activity of macrophages (Chew et al., 1997). 
Anti-osteoporotic. Dietary CLA has positive effects on bone health. CLA 
modulates production of the cytokines that stimulate bone resorption, leading to 
weakening and wasting of bones. Studies on chicks and rats show that dietary CLA 
increases the ash content of bones and also may enhance synthesis of collagen by 
chondrocytes (Watkins et al., 1997). In bone organ culture, CLA decreased ex vivo 
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production of prostaglandin E2 (Li and Watkins, 1998), which is a potent agent regulating 
both bone modeling and remodeling in a concentration-dependent manner (Raisz and 
Loolemans-Beynen, 1974; Chyun and Raisz, 1984). This decrease in prostaglandin E2 by 
CLA might be explained as a competitive inhibition of n-6 fatty acid formation (Sebedio 
et al., 1997) that would lower substrate availability for cyclooxygenase. Finally, CLA 
may up-regulate insulin-like growth factor I in bone to support bone formation. 
Analytical methods of CLA 
Methylation. To analyze CLA concentrations in biological samples by 
chromatographic methods, fatty acid methyl esters are prepared first. Because CLA 
consists of several isomers, the conversion between isomers should be minimized and the 
methylation efficiency maximized in an optimal methylation procedure. Experiments 
have been performed to compare several methylation methods (Kramer et al., 1997). 
Methyl esters of fatty acids in milk and rumen fluid were prepared by using several acid 
(HCI, BF3, acetylchloride, H2S04) or base (NaOCH3, tetramethylguanidine, 
diazomethane) catalysts, or combinations thereof. It was shown that all acid-catalyzed 
procedures resulted in decreased cis/trans (c9, tll-18:2) and increased trans/trans(t9, tll-
18:2) CLA and the production of allylic methoxy artifacts. The base-catalyzed procedures 
gave no isomerization of CLA and no methoxy artifacts, but NaOCH3 did not methylate 
free fatty acids and N-acyl lipids, diazomethane did not methylate fatty acid esters, and 
tetramethylguanidine did not methylate fatty acids in sphingomyelin or phospholipids 
completely. A combination of methods seems to be most suitable, although that increases 
the loss of short-chain fatty acid methyl esters during solvent removal and results in 
excessive handling. The best compromise for milk fatty acids was obtained with NaOCH3 
followed by HCI or BF3, or diazomethane followed by NaOCH3. For rumen samples, the 
best method was diazomethane followed by NaOCH3 (Kramer et al., 1997). 
Separation and identification of CLA isomers. Popular techniques used to 
quantify CLA include high-performance liquid chromatography (HPLC) and gas 
chromatography (GC). In GC separations, long capillary columns with polar liquid 
phases were used (Shantha et al., 1993; Kramer et al., 1997). Several peaks in the CLA 
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isomeric region could be resolved by GC depending on the column and conditions used, 
although the separation was not complete as evidenced by GC-mass spectrometry of the 
2-alkenyl-4, 4-dimethyloxazoline derivatives of CLA (Spitzer et al., 1994). Application 
of silver-ion HPLC resolved CLA isomers based on chain length, double-bond 
configuration, and position of the CLA functional groups in the fatty acid chain and has 
resulted in satisfactory separation (Sehat et al., 1998). 
Dietary sources of CLA 
Dietary sources of CLA for humans include milk fat, meat products, and 
vegetable oils. Animal sources are richer in CLA than are vegetable sources, and foods of 
ruminant origin generally contain more CLA than do foods of nonruminant origin. Dairy 
products are thus one of the major dietary sources of CLA of which c9, tll-18:2 is the 
major isomer (Ha et al., 1989; Parodi, 1977). 
A comprehensive study was performed in 1992 to measure the concentration of 
CLA in over 90 kinds of food (Chin et al., 1992). The highest percentage of CLA was 
found in ruminant meat and milk, especially lamb (5.6 mg/g fat), beef (ground beef: 4.5 
mg/g fat), and bovine milk (5.5 mg/g fat). The proportion of the c9, tll- isomer is much 
higher in those foods than in other foods. For example, lamb contains 92% c9, tll-
isomer. Other processed meats and dairy products have CLA contents that vary between 
0.5 to 7.0 mg/g fat. For example, chicken has 0.9 mg CLA/g fat, shrimp has 0.6 mg 
CLA/g fat, egg yolk has 0.6 mg CLA/g fat, and butter has 4.7 mg CLA/g fat. The c9, tll-
isomer is also the major isomer in these foods. The CLA in butter is 88% c9, tll- CLA. 
In contrast, plant oils contain less CLA, especially the c9, tll- isomer. For example, 
peanut oil has 0.2 mg CLA/g fat, with 46% being the c9, tll-isomer. 
Increasing the CLA concentration in dairy products 
Because CLA has so many beneficial effects on huma11 health, the idea to increase 
the CLA content in the human body becomes attractive in order to exert a protective 
effect against, for example, breast cancer and coronary heart disease. CLA has been 
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identified in human adipose tissue, serum, bile, and duodenal contents. The primary CLA 
in human serum lipids is the c9, tll- isomer. Supplementation of human diets with CLA 
results in significant increases in the CLA content of plasma (Huang et al., 1994). 
Currently, the estimated daily CLA consumption for Americans is several hundred 
milligrams per day (Ha et al., 1987). By using direct extrapolation from rat studies, a 70 
kilogram human would need to consume 3 grams of CLA per day to reach 0.1 % CLA in 
the diet, which is the minimal dietary intake needed to generate a maximal 
anticarcinogenic effect (Ip, 1994). Because of the currently high cost of CLA 
supplements (about 100 dollars per month), more economical supplements need to be 
found to make the health effect of CLA available to all families. One of the easiest ways 
to increase CLA consumption could be to increase the CLA content in foods from dairy 
animals, which are a major source of CLA in human diets. Numerous studies have been 
focused on increasing the CLA concentration of dairy products (Jiang et al., 1996; Kelly 
et al., 1998; Dhiman et al., 1997,1999). 
Biosynthesis of milk fat. Milk fat is composed primarily of triacylglycerols, 
which contain fatty acids that are either of dietary and blood origin or synthesized de 
novo in the mammary gland. Acetate and 3-hydroxybutyrate originating from ruminal 
fermentation are the major carbon sources for de novo fatty acid synthesis, which results 
in almost all 4:0 to 14:0 fatty acids and approximately one-half of the 16:0 fatty acid in 
milk. Fatty acid synthesis occurs in the cytoplasm of the mammary epithelial cell and is a 
sequence of reactions catalyzed by two enzymes. The first reaction is catalyzed by acetyl-
CoA carboxylase and uses acetyl-CoA as the substrate to form malonyl-CoA. Acetyl-
CoA carboxylase is considered to be regulatory in milk fat synthesis, and its activity in 
mammary tissue increases dramatically with the onset of lactation. The second reaction 
sequence is catalyzed by the fatty acid synthetase complex, which is modified in 
mammary tissue of ruminants to produce short- and medium-chain fatty acids because of 
the presence of thioesterase IL This sequence starts with the binding of malonyl- or 
butyryl-CoA to the fatty acid synthetase complex via a thioester linkage. The complex is 
composed of seven enzyme domains and an acyl carrier protein (ACP) domain to which 
all the intermediates are bound. Following binding of malonyl- or butyryl-CoA to the 
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ACP, a sequence of condensation, ketoreduction, dehydration, and enoyl reduction 
reactions completes one cycle of acetate addition. Subsequently, additional malonyl-CoA 
units are added to the carboxyl end of the newly synthesized fatty acid by repeating the 
cycle. This cycle is repeated until the chain is terminated by the fatty acyl deacylase 
(thioesterase II) with formation of fatty acids of short-, medium- or long-chain (16 
carbons) length. 
The reactions of de novo fatty acid synthesis are as follows: 
First enzyme: 
Acetyl-CoA carboxylase 
Acetyl-CoA + CO2 +ATP Malonyl-CoA + ADP + Pi 
Second enzyme (Fatty acid synthase: FAS): 
Malonyl-CoA-ACP transferase 
Malonyl-CoA + FAS ---------- Malonyl-FAS + CoA 
~-Ketoacyl synthetase 
Acetyl-CoA + Malonyl-FAS Acetoacetyl-FAS + CO2 
~-Ketoacyl reductase 
Acetoacetyl-FAS + NADPH + H+ D(-)~-Hydroxybutyryl-FAS + NADP+ 
~-Hydroxyacyl dehydrase 
D(-)~-Hydroxybutyryl-FAS Crotonyl-FAS + H2O 
Enoyl reductase 
Crotonyl-FAS + NADPH + W -------
Fatty acid deacylase 
Butyryl-FAS + NADP+ 
Fatty acyl-FAS + H2O Fatty acid + FAS 
Blood lipids are derived from digestion and absorption of dietary lipids or from 
mobilization of fatty acids from adipose tissue by lipolysis and account for half of the 
16:0 and almost all of the longer chain fatty acids in ruminant milk fat. Dietary lipids 
become incorporated into chylomicrons synthesized by the intestines. The majority of 
diet-derived fatty acids are incorporated into chylomicron triacylglycerol and some into 
chylomicron phospholipids and cholesteryl esters. Fatty acids from adipose tissue are first 
complexed to albumin for transport in blood, and the:n they are utilized by a wide variety 
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of tissues including the mammary gland. Triacylglycerol within plasma VLDL and 
chylomicrons are hydrolyzed by lipoprotein lipase at the capillary endothelium; a 
significant portion of the hydrolyzed fatty acids are taken up by the mammary gland 
(Grummer, 1991). 
As a consequence of the two sources of fatty acid synthesis and hydrogenation of 
unsaturated fatty acids in the rumen, changes in the amount of unsaturated fatty acids in 
the diet of ruminant animals under normal conditions have comparatively little effect on 
the composition of the milk fatty acids. Because of extensive biohydrogenation in the 
rumen, dietary linoleic acid, for example, is partly hydrogenated by the rumen 
microorganizms to stearic acid (Fujimoto et al., 1993), but trans-vaccenic acid (trans-11-
18:1) and other monoenoic isomers and CLA also are found in smaller amounts, all of 
which are absorbed efficiently from the intestines and transported in chylomicrons via the 
lymph and then the plasma to the tissues. Further modification, for example, chain 
elongation, alpha-oxidation, beta-oxidation, and desaturation, then can take place within 
the tissue of both ruminants and nonruminants. For example, some of the stearic acid is 
desaturated to oleic acid (cis-9-18:1). In ruminants, mammary epithelial cells contain an 
active ~-9 desaturase, which decreases the ratio of stearic to oleic acids in ruminant milk 
to that found in nonruminant species (Kinsella, 1970). Therefore, supplementing 
ruminant diets with either stearic acid or linoleic acid tends to increase proportions of 
stearic and oleic acids found in milk fat. However, when palmitic acid is used as a 
supplement, it is essentially the only fatty acid to increase in concentration in the milk fat. 
If palmitate increases, one or more other fatty acids must decrease. 
Milk fat is composed primarily of triacylglycerols, which are formed de novo in 
the mammary gland. The primary source of glycerol for triacylglycerols is glycerol-3-
phosphate, formed either from blood glucose or from the phosphorylation of glycerol 
originating from lipolysis of blood-borne triacylglycerols. Formation of the 
triacylglycerol completes the process of milk fat synthesis. 
Effects of dietary composition on CLA content of bovine milk. Several studies 
have addressed the effects of different dietary regimens on the CLA concentration of 
milk. A number of components in the diets of cattle tend to increase CLA concentration 
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in milk. In a series of in vitro experiments studying the effects of dietary starch and fiber 
on the rates of lipolysis and hydrogenation on rumen digesta of sheep, it was found that 
decreasing the proportion of fiber and increasing the starch content in the diet resulted in 
a slower final hydrogenation step and in increased formation of trans-11-18:1 as a main 
hydrogenation product (Gerson et al., 1985). Accordingly, high concentrate diets 
interfered with the terminal hydrogenation step, and the contents of trans-11-18:1 and c-
9,t-11-18:2 were increased substantially in cows fed high grain diets (Jiang et al., 1996). 
Other research on ruminant nutrition suggested an increase in CLA content in milk from 
cows fed pasture and from those fed supplements of fish meal and linseed and soy oils 
(Dhiman et al., 1997). CLA concentration in milk fat was enhanced by dietary 
supplementation of PUPA-rich oils, especially oils rich in linoleic acid (Kelly et al., 
1998; Sauer et al., 1998). Studies by Banks et al. (1980) examined the effect of amount of 
feed on fatty acid composition and found no significant difference in concentration of 
trans-11-18:1 when changing feeding frequency. This result is in contrast with results 
obtained in the study by Jiang et al. (1996), where the concentrations of c9, tll-18:2 and 
trans-11-18: 1 were significantly higher in the groups fed restricted amounts rather than ad 
libitum amounts of feed. Because there exists a large variation in the CLA isomer 
concentration in raw milk (ranging between 2 and 17 mg/g fat) and because this variation 
could be influenced to a certain amount by dietary treatments (Jiang et al., 1996), it is 
highly advantageous to search for a suitable dietary regimen to increase the 
concentrations of CLA in bovine milk. 
Use of ionophores to manipulate ruminal fermentation. Ionophores are 
naturally-occurring, cyclic polyethers that transport cations across lipid bilayer 
membranes (Lardy, 1968). Different ionophores have different cation selectivity, three-
dimensional structure, binding sites, and mode of action. For example, monensin and 
nigericin bind monovalent cations and serve as antiporters with Ir cations being 
exchanged for Na+ or K+ at the membrane interface, whereas valinomycin is a uni porter, 
transporting K+ across membranes down a concentration gradient without a simultaneous 
reverse movement of Ir (Ramos and Kaback, 1977). 
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Ionophores have been used extensively in the diets of ruminants because of 
increased animal performance partly as the result of the ability of ionophores to favorably 
alter ruminal fermentation. Commonly used dietary ionophores, such as monensin, 
increase the ratio of ruminal propionate to acetate (Newbold et al., 1993) and inhibit 
ruminal methanogenesis (Sauer and Teather, 1987; Domescik and Martin, 1999). It has 
been suggested that ionophores decrease methane production by inhibiting the growth of 
Gram-positive bacteria that produce hydrogen (Fellner et al., 1997). Further studies of the 
effects of ionophores on ruminal biohydrogenation were performed by Fellner and 
colleagues in 1997. In that study, effects of several common ionophores on fatty acid 
biohydrogenation were studied by using continuous in vitro rumen fermentations. 
Ionophores that have Na+ or K+ and Ir antiporter activity are very effective in inhibiting 
18:2n-6 biohydrogenation; a lower content of saturated 18:0 and greater content of 
monounsaturated 18:1 was observed in the ruminal contents. The large accumulation of 
18:1 can not be explained solely by the inhibitory action of the ionophores on the growth 
of Gram-positive bacteria, because the major Gram-positive bacteria, Butyrivibrio 
fibrisolvens, Ruminococcus albus, and Eubacterium sp., possess a great ability to 
hydrogenate linoleic acid to oleic acid but not to stearic acid; only Fusocillus sp. and an 
unnamed Gram-negative bacteria hydrogenate oleate to stearate (Fujimoto et al., 1993; 
Harfoot and Hazlewood, 1988). Moreover, Sauer et al. (1998) found that the changes in 
ruminal lipids that were caused by ionophores are reflected in the fatty acid concentration 
of the milk fat and therefore enhance the nutritional properties of milk. Sauer et al. (1998) 
fed monensin to Holstein cows and observed a decrease in total milk fat percentage and 
milk fat yield compared with cows fed diets without monensin. Decreased saturated fatty 
acids and increased 18: 1, mostly in the t-18: 1 isomer in the milk fat, indicated decreased 
rumen biohydrogenation because of the monensin feeding. Addition of monensin also led 
to an increase in CLA concentrations in milk fat. 
Feeding fat and calcium salts of fatty acids to ruminants. Fat supplementation 
has become more prevalent as a means to increase energy density of the diet of high 
producing dairy cows. However, a decrease of fiber digestion in the rumen (Czerkawski 
et al., 1966) and of milk fat percentage (Palmquist and Jenkins, 1980) may occur 
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depending on the amount and type of fat fed. One reason for the reduction in digestibility 
is inhibition of growth and metabolism of rumen microbes (Hippen et al., 2000) by long-
chain fatty acids. Unsaturated fatty acids are more likely to alter microbial fermentation 
because they are less likely to adhere to feed particles and therefore are more available to 
have toxic effects on ruminal microorganisms (Chalupa et al., 1984). Saturated fatty acids 
may be less toxic to ruminal microorganisms because they react more readily with metal 
ions and form insoluble salts within the rumen (Palmquist et al., 1986; Jenkins and 
Palmquist, 1982). Saturated and unsaturated long-chain fatty acids have less of a negative 
effect on ruminal fermentation when supplemented as calcium salts than as free acids 
(Chalupa et al., 1984; Chalupa et al., 1986). Feeding preformed calcium salts of fatty 
acids or highly soluble calcium ions with free fatty acids may minimize the detrimental 
effects of supplemental fat including CLA on ruminal fermentation. 
Experiments have been performed to study the dissociation of calcium salts of 
long-chain fatty acids in rumen fluid (Sukhija and Palmquist, 1990). Salts of unsaturated 
fatty acids were less satisfactory for maintaining normal rumen function, because 
dissociation is relatively higher. And, calcium salts of long- chain fatty acid were 
satisfactorily stable to pH 5.5. Calcium salts of long-chain fatty acids have been shown 
to be insoluble at normal rumen pH and thus inert toward fermentative digestion in vitro 
(Chalupa et al., 1984). In the abomasum, they are converted by acid to free fatty acids 
and calcium ions. The fatty acids then are absorbed from the small intestine. Because 
calcium salts of fatty acids are insoluble in the rumen, they are partly protected against 
biohydrogenation. A study by Fotouhi and Jenkins (1992), however, did not indicate a 
significant decrease in ruminal loss of linoleic acid in sheep fed calcium linoleate versus 
those fed free linoleic acid. Other studies of ruminal biohydrogenation have shown that 
fatty acids fed as calcium salts were biohydrogenated at a much lower percentage than 
were fatty acids fed in an animal-vegetable fat blend (Wu, 1991), and that total 
unsaturated 18-carbon fatty acids were significantly decreased by feeding linoleic acid as 
the calcium salt than as the free acid to sheep or dairy cows (Enjalbert et al., 1994, 1997; 
Kowalski, 1997). Therefore, it is logical, although untested, to assume that feeding 
calcium salts of CLA to ruminants would result in less conversion of CLA to stearic acid 
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in the rumen than would feeding the free fatty acid form of CLA, resulting in larger 
availability of CLA from the dietary calcium salt of CLA for absorption from the 
intestine. 
Objectives of the project 
On the basis of the preceding discussion of the literature, it is highly advantageous 
and practical to pursue an efficient way to maximize the dietary absorption of CLA by 
ruminants and to increase the CLA concentration in dairy products because of the health 
value of CLA to humans. Therefore, the objectives of the current study were to: 
1) Compare the effects of feeding CLA as a calcium salt or as a free fatty acid on 
availability of CLA and other long-chain fatty acids for absorption from the sheep 
intestine, 
2) Determine the effect of feeding CLA as a free acid and as a calcium salt on CLA 
content of milk, and 
3) Evaluate the effect of supplementing a CLA-containing diet with a linoleic acid-rich 
oil on CLA content of milk. 
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EFFECTS OF DIETARY SOURCES OF CLA ON AVAILABILITY 
OF CLA AND OTHER LONG-CHAIN FATTY ACIDS FOR 
ABSORPTION FROM THE INTESTINE OF SHEEP 
A paper to be submitted to the Journal of Animal Science 
Huang, Y, H. Al-Jobeile, S. L. Oren, A. Trenkle, J. W. Young, and D. C. Beitz 
Abstract 
Six sheep were used in two replications of a 3x3 Latin square design to compare 
the effects of dietary sources of conjugated linoleic acid (CLA) on availability of CLA 
and other long-chain fatty acids for absorption from the intestine. The three diets chosen 
to test these effects were a basal (control) diet, which contain 45% alfalfa hay, 50% 
cracked com, and 5% soybean meal, the basal diet plus 1 % CLA as the free acid, and the 
basal diet plus 1 % CLA as the calcium salt. Each period of feeding lasted three weeks, 
during which feed, rumen, duodenal, and fecal samples were collected to determine 
apparent digestibility of diet components, biohydrogenation of CLA in the rumen, and 
intestinal absorption of CLA and other long-chain fatty acids. It was found that dietary 
supplementation of CLA had no significant effect on dry matter and crude protein 
digestibility but increased lipid digestibility. Dietary CLA had no significant effects on 
ruminal VF A distribution. The availability of CLA for intestinal absorption and the 
intestinal absorption efficiency of CLA were increased significantly by supplementing 
the diet with CLA. About 96.7% of CLA fed as the free acid was biohydrogenated in the 
rumen, whereas feeding CLA as the calcium salt decreased biohydrogenation to about 
90.1 %. Thus, feeding the calcium salt of CLA is a better way to increase availability of 
CLA for intestinal absorption than feeding CLA as the free acid. 
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Introduction 
Conjugated linoleic acid (CLA), a mixture of geometric and positional isomers of 
linoleic acid with conjugated double bonds, has been of particular interest to nutritional 
scientists in the past few years. Numerous studies have disclosed the anticarcinogenic (Ip 
et al., 1991) and antiatherogenic (Lee et al., 1994; Nicolosi et al., 1997) properties of 
dietary CLA as well as its effects on immune function (Cook et al., 1997) and bone 
modeling (Li and Watkins, 1998). Supplementation of the human diet with CLA leads to 
increased CLA content in serum phospholipids (Huang et al., 1994), indicating the 
prudence and practicability of increasing CLA content in humans by intake of CLA-
enriched diets. 
Because dairy products from ruminants are a major source of dietary CLA for 
humans (Chin et al., 1992), there have been several studies focused on different 
approaches to increase the CLA concentration in dairy products, such as feeding a high-
grain diet (Jiang et al., 1996) and adding ionophores to diets (Feller et al., 1997), both of 
which alter the biohydrogenation process in the rumen. 
The synthesis of CLA in the rumen through biohydrogenation (Fujimoto et al., 
1993) has been studied thoroughly. One possible pathway is a two-step process. Most of 
the rumen bacteria with hydrogenation ability (e.g., Butyrivibrio fibrisolvens) isomerize 
linoleic acid to c9, tll-Cl8:2 by an isomerase in the first step. The double bond at 
position 9 in the CLA is preferentially reduced to form tll-C18:l. In the second step, 
which is thought to be the rate-limiting step, rumen bacteria reduce the tll-C18:1 to 
stearic acid ( Kepler and Tove, 1967; Hughes et al., 1982). 
Because c9, tll-C18:2 is formed in the first step of biohydrogenation of linoleic 
acid, it is reasonable to assume that availability of dietary CLA for ruminants could be 
increased if biohydrogenation is inhibited. Administering CLA into the rumen as 
insoluble salts of calcium could potentially decrease the biohydrogenation of CLA to 
stearic acid. Calcium salts of fatty acids have been a popular substitute for fat 
supplementation of the diet of ruminants (Grurnrner, 1988). Calcium salts are inert at 
normal rumen pH and therefore decrease the antibacterial activity of long-chain fatty 
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acids, which usually results in decreased digestibility of fiber and fat (Palmquist and 
Conrad, 1980). Yet, little is known about the effects of insoluble calcium salts of fatty 
acids on the biohydrogenation of CLA to stearic acid in the rumen, and the answer could 
provide an efficient way to increase CLA absorption from the diet by ruminants. We 
hypothesized that the inert calcium salts of CLA will decrease the biohydrogenation of 
CLA in the rumen of sheep and thus increase the availability of dietary CLA for 
absorption from the intestine when compared with adding CLA as a free acid to the diet. 
Therefore, the objective of this study was to evaluate the effects of feeding CLA as the 
free acid and as the calcium salt on availability of CLA and other long-chain fatty acids 
for absorption from the intestine of sheep and hence to search for a suitable way to 
increase dietary CLA absorption by ruminants. 
Materials and Methods 
Experimental design. Six mature sheep were fed individually in pens and 
managed in accordance with guidelines provided by the Iowa State University Committee 
on Animal Care. They were fitted surgically with plastic cannulae in the rumen and in the 
duodenum. This experiment was designed as two replications of a 3 x 3 Latin square. The 
three largest sheep were the first replication and the three smallest sheep were the second 
replication. The initial weight of sheep ranged from 112 kg to 144 kg. 
Three diets were used. Sheep were fed 1 kg (on an as-fed basis) of diet each day, 
which was formulated to provide slightly more than the requirements for maintenance. 
The control (basal) diet contained 450 g of ground alfalfa hay, 500 g of ground shelled 
corn, and 50 g of soybean meal (SBM). Table 1 shows the chemical composition of each 
ingredient. Treatment 1 is the basal diet plus 1 % CLA as the free acid, and treatment 2 is 
the basal diet plus 1 % CLA as the calcium salt. One gram of chromic oxide was added 
per day to the diet as a marker. Dietary CLA was prepared from sunflower oil and 
contained around 67% CLA (Conlinco, Inc., Detroit Lakes, MN). The calcium salt of 
CLA was prepared (Bioproducts, Inc. Las Vegas, NV) according to the following 
formula: 100.44 g oil+ 18.09 g Cao + 17.79 g H20. Each period of feeding lasted 3 
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weeks; there was a one-week lapse between periods before transferring sheep to a new 
diet to minimize carry-over effects of treatments between periods. 
Collection of samples. During each feeding period, duodenal fluid was collected 
from each sheep three times a day on days 1, 2, 3, and 4 of week 3 with collection times 
being rotated forward one hour each day so that each sheep was sampled every hour 
during a 12-hour period over the 4 days. Individual duodenal samples of 100 ml for each 
period for each sheep were mixed, lyophilized, and stored at -20°C until analyzed for 
fatty acid composition and chromic oxide. 
Approximately 200 ml of ruminal fluid were taken as a sample from the ruminal 
cannula at 0, 2, 4, and 6 h after the morning feeding on day 6 of week 3 of each treatment 
period. Aliquots of samples were centrifuged at 7000xg and mixed with 20% 
metaphosphoric acid (0.25 N HP03) for volatile fatty acid analyses. The remainder of the 
samples was mixed with 6 N HCl at 10% of total volume for ammonia quantification. 
Samples were stored at -20°C u:ntil analysis. Feed samples were taken two days before 
rumen fluid collections during each treatment period and continued for five subsequent 
days for dry matter, protein, andlipid analyses. Fecal samples were collected on days 3, 
4, and 5 of week 3 for each treatment period, lyophilized, and stored at -20°C until 
quantification of fatty acids and chromic oxide. 
Chemical analyses. Dry matter in alfalfa hay, corn, SBM, and feed was 
determin~d by drying at 65°C for 48 h (AOAC, 1991) in a forced-air oven. Nitrogen in 
feed and feces was quantified by the Kjeldahl analysis (AOAC, 1991). Lipid content of 
feed and feces was determined by the Bligh and Dyer (1959) procedure. 
Ammonia-N concentration of ruminal fluid was determined by the hypochlorite 
procedure (Chaney and Marbach, 1962). A purge-and-trap apparatus connected to a gas 
chromatograph (GC) was used to analyze the volatile fatty acids (VFA) from ruminal 
samples by following the procedure of Erwin et al. (1961). Percept II and Purge-and-Trap 
concentrator 3000 (Tekmer-Dohrmann, Cincinnati, OH) were used to purge and collect 
volatiles. Two milliliters of rumen fluid was placed in a vial ( 40 ml) and purged with helium gas 
(40 ml/min) for 15 min, and volatiles were trapped at 20°C using a Tenax/Silica 
gel/Charcoal column (Tekmar-Dohrmann) and desorbed for 2 min at 220°C. The 
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desorbed volatiles were concentrated at -100°C by using a cryofocusing unit before being 
desorbed thermally (220°C) and injected (30 sec) into a capillary GC column. Ramped 
oven temperature was used. The initial oven temperature was 0°C and was held for 1.50 
min. After that, the oven temperature was increased to 20°C at 4 °C per min, increased to 
80°C at 10°C per min, increased to 180°C at 20°C per min and then kept at 180°C for at 
4.50 min. The column was an HP-Wax (7.5 m) and HP-5 (30 m, Hewlett-Packard Co., 
Wilmington, DE) combined column, with a flow pressure of helium set at 12 psi. A mass 
selective detector (MSD, HP 5973, Hewlett-Packard Co.) was used to determine volatile 
components. The ionization potential of the MS was 70 e V, and the scan range was 40-
450. Identification of volatiles was achieved by comparing mass spectral data of samples 
with those of the Wiley library (Hewlett-Packard Co.) and also of the standards. The area 
of each peak was integrated by using ChemStation software (Hewlett-Packard Co.), and 
total ion counts x 103 were reported as an indicator of volatiles generated from ruminal 
samples. 
Chromic oxide in duodenal and fecal samples was extracted from ashed samples 
with phosphoric acid and quantified by an atomic absorption spectrophometer (William 
et al., 1962). Duodenal and fecal dry matter flow (g/d) was estimated by dividing the 
amount of chromium fed by the chromium concentration in duodenal digesta and feces. 
Duodenal, fecal, and ruminal samples were first acidified by 6 N HCl at 70°C for 
1 h to dissolve the calcium salt; lipids then were extracted by the Bligh and Dyer 
procedure (1959). The extracted lipid were dissolved in methanol, and fatty acids were 
quantified by a GC (model 5890; Hewlett-Packard, Palo Alto, CA) by using a NaOCH3-
catalyzed methanolysis procedure (Kramer et al., 1997). Separation of the fatty acid 
methyl esters was performed on a SP-2560 fused silica capillary column (100 m x 0.25 
mm i.d. x 0.2 µm film thickness, Supelco Inc., Bellefonte, PA) by using helium as carrier 
gas at a pressure of 30 psi. Oven temperature was maintained at 70°C for 4 min, then 
programmed at 13°C/min to 175°C, held there for 27 min, programmed at 4°C/min to 
215°C, and finally held there for 31 min. The internal standard fatty acid was Cl9:0. 
Identification and quantification of CLA and other long-chain fatty acids were obtained 
by comparison to commercially available reference standards (Nu-Check Prep, Elysian, 
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MN). Fatty acid composition of the CLA oil as well as experimental diets was 
determined. 
Statistical analysis. Data were analyzed by analysis of variance (Steel and Torrie, 
1960) by the General Linear model procedure of SAS. The Model employed for analysis 
of variance was Yijk = µ + •<Xi + Pj + 'tk + Ei.jk where µ = mean, <Xi = ith sheep, Pj = jth 
period, 'tk = kth treatment, and Ei.jk = residual. Tukey' s multiple comparison method was 
used for all pairwise comparisons among the three diets. 
Results and Discussion 
Diets. Chemical compositions of the experimental diets are shown in Table 2. 
Concentration of dry matter was similar across three diets; crude protein concentration 
was diminished by addition of CLA to the diets. The lipid content (dry matter basis) was 
higher for the CLA-supplemented diets. The CLA-containing oil that was fed either as 
the full acid or as the calcium salt contained 28 wt% c9,tll-C18:2 ( with a small 
proportion of other CLA isomers like t9, cll-C18:2) and 37 wt% of t10,cl2-C18:2 (with 
a small proportion of other CLA isomers like c9,cll-C18:2) and a total of 67 wt% of 
CLA isomers. The major nonCLA acid was C18:1 followed by similar amounts of C16:0, 
C18:0, and C18:2 (Table 3). Fatty acid compositions of each of the three diets are 
presented in Table 4. No CLA was detected in the basal diet. Linoleic acid was the major 
fatty acid present in the basal diet; the two major isomers were present at about 25 wt% 
of the total fatty acids in the two CLA-supplemented diets. The two CLA-supplemented 
diets had higher proportions of C12:0, Cl6:l, and C18:0 and lesser concentrations of 
C16:0, C18:l, C18:2, C18:3, and C20:0. Fatty acid concentration of the CLA-
supplemented diets is higher (18 mg/g DM) than that of the basal diet. 
Feed intake and digestibility. Dry matter intake (Table 5) was not affected by 
supplementing CLA in the diet, which is compatible with the general thoughts that 
increased amounts of a single source of palatable fat up to 5% of diet dry matter will not 
affect feed intake (Hippen et al., 1996). Also, the sheep were fed at a level just slightly 
above maintenance, which increases the likelihood of all feed being consumed each day. 
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Total protein intake decreased only slightly in the CLA-supplemented diets because of 
dilution of feed with the CLA. Feeding the CLA-supplemented diets resulted in similar 
increases in lipid intake, which is consistent with the findings of Grummer (1988) when 
they fed cows diets with a supplemental oil and calcium salt of fatty acids of the same oil. 
The difference in lipid intake between the CLA-supplemented and basal diets is 
accounted for by the difference in lipid content of the three diets. 
Nutrient digestibility. Total tract dry matter digestion was not affected by 
supplemental dietary CLA (Table 6). Also, supplementing CLA as the acid or as the 
calcium salt had no effect on crude protein digestion, which is consistent with some 
reports (Boggs et al., 1987; Grummer, 1988; Palmquist, 1988; Schauff and Clark, 1988), 
but not others (Ohajuruka et al., 1991; Palmquist and Conrad, 1978), where 
supplementing fat increased total tract apparent nitrogen digestion. CLA supplemented as 
the free acid or as the calcium salt increased total dietary lipid digestibility, which is 
consistent with other studies concerning effects of fat or calcium salts of fatty acids 
(Grummer, 1988; Palmquist and Conrad, 1978). The digestibility of the supplemented-
fat was 83.1 % for the free .acid supplementation and 85.7% for the calcium salt 
supplementation, whereas the digestibility of lipid in the basal diet was only 50.5%. The 
increase in lipid digestibility suggests that the added CLA was more digestible than the 
lipid component of the basal diet or that additional fat supplementation diminished 
endogenous lipid secretions, which results in a more accurate estimate of true lipid 
digestibility. 
In ruminant animals, digestion has complex initial stages. Considerable 
metabolism of dietary lipid occurs before the digesta reach the small intestine. That is, in 
the rumen, dietary triacylglycerol, which is water-insoluble, undergoes microbial 
lipolysis to form end products such as free fatty acids or monoacylglycerol that more 
readily form bile salt (Palmiquist and Jenkins, 1980). At the same time, only emulsified 
triacylglycerol can be hydrolyzed by pancreatic lipase when they arrive at the small 
intestine. Extensive hydrolysis of esterified fatty acids occur in the rumen under the 
action of microbial lipases and the released unsaturated 18-carbon fatty acids are 
progressively biohydrogenated to Cl8:2 and Cl8:1 and eventually to C18:0 (Leat and 
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Harrison, 1975). Yet, as Palmquist and Jenkins (1980) pointed out, when those fatty 
acids, especially the unsaturated fatty acids are provided in excess, ruminal microbial 
metabolism is depressed. Calcium salts of long-chain fatty acids commonly are 
considered as inert fats because of their insolubility in the rumen. Dietary lipids rich in 
unsaturated fatty acids are more digestible than are dietary lipids rich in saturated fatty 
acids (Borsting et al., 1992; Palmquist and Jenkins, 1980). Schineider et al. (1988) 
showed that calcium salts of fatty acids are more digestible than the same fatty acids as 
the free acids, possibly because of the protection of unsaturated fatty acids from ruminal 
biohydrogenation. On the other hand, digestibility of fat was lower when high amounts of 
calcium salts (6% of dry matter) were fed to dairy cows because of the limited capacity of 
the small intestine to absorb fat (Jenkins and Palmquist, 1984; Ngidi et al., 1990). Results 
from our study are consistent with those of Palmquist and Jenkins (1980) who showed 
that highly unsaturated dietary oils are more digestible than those in a low-fat basal diet. 
Rumen VF A and ammonia. To study whether supplemental dietary CLA 
influences ruminal fermentation, the concentration of VF A and ammonia in rumen fluid 
was determined. Because no interaction between time and concentration of VF A or 
ammonia was observed, mean of VF A or ammonia concentrations from ruminal samples 
taken at 0, 2, 4, 6 h after the morning feeding are presented in Table 7. Supplementing 
CLA as the free fatty acid or as the calcium salt to the diet did not change concentrations 
of total VFA or proportions (mol/100 mol) of individual VFA in the rumen fluid. The 
acetate to propionate (A:P) ratio was also similar among the three experimental diets, 
suggesting that supplemental CLA had no negative effects on cellulolytic activity. 
Nonsignificant differences in concentrations of ruminal ammonia among dietary 
treatments suggested that supplemental CLA at 1 % of the diet had no effect on protein 
metabolism in the rumen. 
Supplemental dietary fat can inhibit fiber digestion in the rumen when fed at high 
amounts (Palmquist and Conrad, 1978). Addition of lipid to the diet at 10% of diet dry 
matter decreases digestion of structural carbohydrates in the rumen by almost 50%, 
leading to decreased production of VFA and lower acetate to propionate ratios (Jenkins 
and Palmquist, 1984). And unsaturated free fatty acids are more inhibitory than are the 
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saturated fatty acids (Chalupa et al., 1984). In our study, supplementing CLA at 1 % of 
the diet did not adversely affect rumen digestion. Typically, free fats are limited to 3% of 
dietary dry matter to maintain a normal environment for rumen bacteria (Hippen et al., 
1996). The addition of calcium salts of fatty acids protects against the adverse effect of 
dietary lipids and enables normal rumen fermentation (Jenkins and Palmquist, 1984). The 
fatty acids inbibit fermentation less when the free carboxyl group is in the salt form. 
Availability of long-chain fatty acids for absorption from the intestines. 
Availability of long-chain fatty acids was calculated from the flow of digesta into the 
small intestine and the fatty acid composition of that digesta (Table 8). There was more 
C16:0 available for absorption from the intestine for CLA-supplemented diets. 
Availability of C18:0 and Cl8:l for absorption was also higher in sheep fed CLA-
supplemented diets, as a result of biohydrogenation of CLA in the rumen. Supplementing 
the diet with CLA as the free acid increased the amount of CLA available in the intestine 
for absorption compared with the basal diet, and feeding CLA as the calcium salt 
increased it even more. Therefore, feeding CLA as the calcium salt decreases 
biohydrogenation of CLA in the rumen. It should be noted that the amount of CLA 
available for absorption in duodenal digesta is comparatively small (0.6 g/d as the free 
acid and 1.3 g/d as the calcium salt) compared with the original supplementation of 10 
g/d CLA in the experimental diets. Thus, most of the dietary CLA was hydrogenated in 
the rumen. 
Ruminal disappearance of long-chain fatty acids is common in ruminant studies. 
A previous study by Wu et al. (1991) showed that lipid disappearance from the rumen for 
cattle and sheep averaged 8 g/100 g of fatty acid intake. In other studies, variable values 
were reported for ruminal disappearance of long-chain fatty acids, ranging from 20% to 
30% for different dietary regimen (Bauchart et al., 1987; Jenkins and Palmquist, 1986). 
In our study, about 22% of dietary fatty acids disappeared in the rumen for the basal diet, 
33% for the free CLA acid diet, and 29% for the calcium salt of CLA diet. This 
disappearance is consistent with the expectation that lipid loss from the rumen is more 
common for diets with added fat than in those without added fat (Hippen et al., 1996; Wu 
et al., 1991). Still, CLA supplementation as the free acid or as the calcium salt increased 
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the total fatty acid flow to the duodenum. Although small in amount, C15:0 and Cl 7:0, 
which were not present in diets, appeared in duodenal contents. These odd-numbered 
fatty acids are unique to ruminal microorganisms (Noble, 1981). Extensive 
biohydrogenation was shown by the tremendously increased C18:0 in the duodenal flow 
compared with dietary amounts. The CLA-supplemented diets result in even larger 
increases in C18:0 because of Cl8:0 formation from CLA. The C18:1 disappearing from 
the rumen may be partly reduced to C18:0 and partly absorbed by the rumen epithelium 
(Goosen, 1975). Because of extensive biohydrogenation (86.9% for C18:2 and 70.1 % for 
C18:3), less than 2 g of C18:2 and less than 0.5 g of C18:3 pass through the duodenum 
per day. Similar results were seen in another study (Ingle et al., 1972). 
Supplemental dietary CLA was largely biohydrogenated in rumen. Assuming that 
CLA for the basal diet is the amount of CLA produced by ruminal fermentation every 
day, then the supplemental dietary CLA was 96.7% biohydrogenated when CLA was fed 
as the free acid and 90.1 % biohydrogenated when CLA was fed as the calcium salt. 
Therefore, the calcium salt partly prevented biohydrogenation in the rumen compared 
with the free acid. In the study by Fotouhi and Jenkins (1992), ruminal loss of 
supplemental fat was 92.9% and 94.6%, respectively, for free linoleic acid and calcium 
linoleate in sheep, suggesting that calcium linoleate did not escape biohydrogenation by 
rumen bacteria. However, other studies of ruminal biohydrogenation have shown that 
fatty acids fed as the calcium salts were biohydrogenated at a much lower percentage 
(57%) than were fatty acids in animal-vegetable fat blends (87%) (Wu, 1991), and that 
ruminal biohydrogenation of total unsaturated 18-carbon fatty acids were significantly 
lower in a diet supplemented with linoleic acid as the calcium salt (75%) compared with 
that of the control diet (83%) (Enjalbert et al., 1994, 1997; Kowalski, 1997). 
Absorption of fatty acids from the intestine. Absorption of long-chain fatty acids 
was determined by comparing the daily input of fatty acids entering the small intestine 
with the daily output of fatty acids excreted in the feces (Table 9). These data are 
influenced by biliary and intestinal epithelial fatty acids and by fatty acid synthesis by 
intestinal microorganisms. The diets supplemented with CLA increased digestibility of 
CLA but not of other long-chain fatty acids. The differences in intestinal absorption of 
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fatty acids from the experimental diets indicate the importance of the form in which lipids 
are presented to the intestine. Supplementing CLA the free acid resulted in slightly higher 
apparent intestinal digestibility of total 18-carbon fatty acids. The unsaturated to saturated 
ratio of total 18-carbon fatty acids in duodenal digesta averaged 0.56 in CLA-
supplemented diets and 0.46 in basal diets, indicating that the total 18:..carbon fatty acids 
influx was more unsaturated with the CLA-supplemented diet. Because unsaturated FA 
are more hydrophilic, more readily form micelles with bile salts, and more readily pass 
through the unstirred water layer adjacent to the microvilli of the small intestine (Wu et 
al., 1991), they are more digestible than saturated FA with the same chain length. 
Fatty acids presented as calcium salts are generally thought to be more digestible 
than free acids (Hippen, 2000; Schneider et al., 1988). This finding was not confirmed by 
the present study. In contrast to the report of Steel and Moore (1968), which showed that 
C18:0 is less digestible than C16:0 because shorter chain fatty acids are more digestible 
than longer ones, apparent digestibility of C16:0 was lower than that of C18:0 in all the 
diets in our study. This finding, however, is consistent with results from Wu et al. (1991). 
Our observation may be confounded by the higher content of C16:0 than of C18:0 in bile 
secretions (Eorsting and Weisbjerg, 1989; Wu et al., 1991), such that apparent 
digestibility is decreased by the endogenous contribution. The increased absorption rate 
of C18:0 in CLA-supplemented diets is consistent with the idea of Grummer et al. (1991), 
who suggested that the presence of PUF A in the digesta along with SF A may enhance 
absorption of the SFA by increasing dispersion of the fatty acids and increasing small 
micelle formation. 
Conclusions 
Supplementing a basal diet with 1 % CLA as the free acid or as the calcium salt 
(1) had no effect on dry matter and crude protein digestibility and ruminal VFA 
composition, (2) increased lipid digestibility, (3) increased the percentage of CLA 
entering the duodenum that was absorbed. Adding 1 % CLA as the free acid to the basal 
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diet increased CLA availability for absorption in the intestine. Feeding CLA as a calcium 
salt decreased its biohydrogenation in the rumen. 
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Table 1. Chemical composition of .alfalfa hay, com, and soybean meal1 
Parameter Alfalfa Hay 
Dry matter3 88.7 
TDN 55 
Crude protein 19.1 
Calcium 1.0 
Phosphorus 0.25 
Each value is the average of triplicate assays 
2 SBM = Soybean meal. 
Corn 
(%) 
88.9 
87 
8.0 
0.02 
0.32 
3 As-fed basis; all other components are dry matter basis. 
SBM2 
91.1 
87 
47 
0.34 
0.70 
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Table 2. Chemical composition of diets1 
Diet2 
Chemical analysis Basal CLA Ca(CLA)z 
(%) 
Dry matter3 88.0 88.4 88.5 
Crude protein 4 16.5 15.4 15.2 
Lipid4 4.4 6.1 6.1 
Each value is the average of triplicate assays. 
2 Basal = Basal diet, CLA = Basal diet + 1 % CLA as free acid, Ca(CLA)z = Basal diet + 1 % CLA as 
calcium salt, CLA content of admistered product contained 67% CLA. 
3 As-fed basis. 
4 Dry matter basis. 
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Table 3. Fatty acid composition of the supplemental CLA-containing oil used in the 
diets1 
Fatty acid CLA-containing oil 
(weight%) 
C12:0 1.09 
C14:0 0.36 
C16:0 5.18 
C16:1 0.43 
C18:0 5.92 
C18:l 12.80 
C18:2 5.30 
Cl8;3 1.66 
Total CLA 67.18 
c9,tl 1-C18:22 28.02 
t10,c12-C18:23 37.05 
C20:0 0.08 
Each value is the average of triplicate assays. 
2 A mixture of CLA isomers, mainly of c9, t11- CLA, with small proportion of t9, cl 1-CLA. 
3 A mixture of CLA isomers, mainly oftl0, cl2-CLA, with small proportion of c9, cll-CLA. 
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Table 4. Fatty acids composition of the experimental diets1 
Diet2 
Fatty acid Basal CLA Ca(CLAh 
------------------------------g/ 1 00g fatty acids---------------------------
Cl2:0 0.21 0.54 0.54 
C14:0 0.36 0.36 0.36 
C16:0 15.50 11.60 11.81 
C16:1 0.21 0.29 0.29 
C18:0 2.17 3.59 3.58 
C18:1 19.27 16.83 16.84 
C18:2 54.83 34.25 34.33 
C18:3 6.11 4.43 4.43 
CLA 25.39 25.29 
c9,tll-Cl8:23 10.59 10.56 
t10,cl2-C18:24 14.00 13.95 
C20:0 0.31 0.23 0.23 
Total FA5, mg/g DM6 23.90 42.04 41.76 
Each value is the average of triplicate assays. 
2 Basal = basal diet, CLA = basal diet+ 1 % CLA as free acid, Ca(CLAh = basal diet+ 1 % CLA as calcium 
salt. 
3 A mixture of CLA isomers, mainly of c9, tl 1- CLA with small proportion of t9, c 11-CLA . 
4 A mixture of CLA isomers, mainly oftl0, cl2-CLA with small proportion of c9, cll-CLA. 
5 FA= fatty acids. 
6 DM = dry matter. 
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Table 5. Daily intake of dry matter, crude protein, and lipid by sheep 
Feed component 
Diet1 Dry matter Protein Lipid 
--------------------------------------------g/ d------------------------------------------
Basal 
CLA 
Ca(CLAh 
880 
884 
885 
145.2 
136.1 
134.5 
39.1 
53.8 
54.0 
1 Basal= Basal diet, CLA = Basal diet+ 1% CLA as free acid, Ca(CLAh = Basal diet+ 1 % CLA as 
calcium salt. 
42 
Table 6. Apparent digestibility of diet component by sheep 
Item 
Dry matter 
Crude Protein 
Lipid 
Basal CLA Ca(CLAh 
-------------------------------------(% )------------------------------------------
78.3 
68.1 
sos 
76.9 
66.8 
59.4b 
75.4 
67.0 
60.2b 
fat supplement 83.1 85.7 
SE 
1.3 
2.1 
1.2 
1 Basal= Basal diet, CLA = Basal diet+ 1 % CLA as free acid, Ca= Basal diet+ 1 % CLA as calcium salt 
2 Standard error of the mean. 
a,bMeans on the same row with different superscripts differ (P < 0.05). 
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Table 7. Rumen volatile fatty acids and ammonia 1 
Diet2 
Parameter Basal CLA Ca(CLAh SE3 
Total VFA, mmol/L 57.6 62.4 66.5 4.9 
Acetic, mol/100 mol 58.4 57.6 58.8 1.6 
Propionic, mol/100 mol 20.0 20.6 20.7 1.5 
Isobutyric, mol/100 mol 1.4 1.3 1.3 0.1 
Butyric, mol/100 mol 16.2 15.9 15.3 0.9 
Isovaleric, mol/100 mol 2.9 3.0 2.6 0.4 
Valerie, mol/100 mol 1.3 1.7 1.3 0.2 
Acetate: Propionate 3.0 2.9 3.0 0.2 
Ammonia, mg/100 ml 16.9 16.2 15.9 1.7 
Mean from samples taken 0, 2, 4, and 6 h after the morning feeding is presented; each value is the average 
of triplicate assays. 
2 Basal = basal diet, CLA = basal diet+ 1 % CLA as free acid, Ca(CLAh = basal diet+ 1 % CLA as calcium 
salt. 
3 Standard error of the mean. 
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Table 8. Availability of CLA and other long-chain fatty acids for absorption from the 
intestinal tract of sheep 
Diet1 
Basal CLA Ca{CLAh 
Fatty acid Diet Chyme Diet Chyme Diet Chyme SE2 
----------------------------gl d----------------------------------
C14:0 0.08 0.27 0.13 0.33 0.13 0.36 0.03 
C15:0 0.22 0.24 0.29 0.03 
Cl6:0 3.26 3.18a 4.31 3.77b 4.93 4.49c 0.12 
C17:0 0.15 0.16 0.19 0.02 
C18:0 0.46 8.63a 1.33 12.63b 1.33 12.94b 0.27 
C18:l 4.05 1.86a 6.25 4.12b 6.22 3.96b 0.22 
C18:2 11.53 1.42 12.73 1.54 12.68 1.89 0.15 
C18:3 1.28 0.43 1.65 0.43 1.64 0.49 0.03 
CLA 0.29a 9.44 0.62b 9.35 1.28c 0.07 
Total 20.66 16.45a 35.84 23.84b 36.28 25.89c 0.26 
1Basal = Basal diet, CLA = Basal diet + 1 % CLA as free acid, Ca(CLA)z = Basal diet + 1 % CLA as 
calcium salt. 
2 Standard error of the mean for fatty acid in chyme. 
a,b,cMeans on the same line with different superscripts are different (P<0.05). 
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Table 9. Percentage of CLA and other long-chain fatty acids entering the duodenum that 
are absorbed from the intestine of sheep1 
Fatty acid Basal CLA Ca(CLAh SE 
-------------------------_ ---------------( % )------------------------------------------
C14:0 68.4 68.5 70.4 4.0 
Cl5:0 64.8 62.2 69.4 3.1 
C16:0 82.5 83.6 83.7 1.5 
C17:0 62.4 57.9 60.l 3.3 
C18:0 84.3 89.2 87.0 1.4 
C18:1 89.4 92.6 90.6 1.5 
C18:2 87.0 92.4 91.4 1.4 
C18:3 81.5 82.4 83.7 1.8 
CLA 65.6" 89.9b 89.lb 2.5 
Cl8:n4 85.0" 90.0b 88.2"b 0.9 
Each value is the average of triplicate assays. 
2Basal = basal diet, CLA = basal diet+ 1 % CLA as free acid, Ca(CLAh = basal diet + 1 % CLA as calcium 
salt. 
3 Standard error of the mean. 
4 Total 18-carbon fatty acids. 
a,b Means on the same row with different superscripts differ (P < 0.05). 
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FEEDING TO INCREASE THE CONTENT OF CONJUGATED 
LINOLEIC ACID IN MILK 
A paper to be submitted to the 
Journal of Dairy Science 
Huang, Y., B. J. Bradford, N. G. Heig, J. W. Young, and D. C. Beitz 
ABSTRACT 
To evaluate the relative effectiveness of CLA as the free acid and as the calcium 
salt to increase CLA in milk fat, 36 Holstein cows were fed six diets in a completely 
randomized block design with a 4-wk period for each replication. The control diet was a 
total mixed ration consisting of com silage, alfalfa hay, and concentrates. The control diet 
was supplemented based upon dietary dry matter with 1) 5% soy oil, 2) 1 % CLA as free 
acid, 3) 1 % CLA as the calcium salt, 4) 4% soy oil plus 1 % CLA as the free acid, or 5) 
4% soy oil plus 1 % CLA as the calcium salt. Feed, rumen fluid, blood, and milk samples 
were collected and analyzed to determine the effects of CLA supplementation on dry 
matter intake, rumen VF A, blood fatty acid concentrations, milk yield, and milk 
composition. Compared with the control diet, no significant effects of dietary 
supplementation were found on daily milk yield, milk protein concentration and 
production, or milk lactose concentration and production. Supplementation of unsaturated 
fatty acids as soy oil, CLA, or Ca(CLA)2 decreased milk fat concentration and production 
but had no effects on rumen VF A concentrations. Total fatty acid concentration in plasma 
was increased by all dietary lipids tested. Concerning the milk fatty acid profile, the 
weight percentage of CLA was increased from 0.4% to 0.7% with 1 % CLA and to 1.3% 
with 1 % CLA plus soy oil. Supplementation with Ca(CLA)2 increased the CLA content 
of milk fat to 0.9%; feeding Ca(CLA)2 with soy oil increased the CLA in milk fat to 
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1.4%. Soy oil supplementation increased CLA content to 1.2% as well. In summary, 
adding 5% soy oil was as efficient to increase CLA concentrations in milk fat as feeding 
1 % CLA as the free acid or as the calcium salt with or without 4% soy oil. Feeding CLA 
as the calcium salt resulted in greater concentrations of CLA in milk fat than did feeding 
CLA as the free acid. Dietary supp~ementation of 5% soy oil or 4% sol oil+ 1 % CLA as 
the free acid or the calcium salt increased the yield of CLA in milk. 
INTRODUCTION 
Conjugated linoleic acid (CLA) has many beneficial effects including 
anticarcinogenic activity (3, 48), antiantherogenic activity (38, 43), antiobesity (47), and 
ability to stimulate immune function (40). By extrapolation from rat studies, daily intakes 
of approximately 3 g of CLA should have anticancer effects in humans (28). Because the 
principal dietary sources of CLA for humans are dairy products and other foods derived 
from ruminant animals (2, 8), the strong positive association of dietary CLA with 
improved human health generates enthusiasm for developing nutritional methods to 
increase the CLA content of animal-derived foods. 
The CLA content of bovine milk ranges from 2-17.7 mg/g of fat (32). A number 
of studies have demonstrated substantial increases of CLA in milk fat by dietary and 
management practices. Providing additional CLA precursors in the diet (15), decreasing 
the forage to concentrate ratio (33), and supplementing the diet with ionophores such as 
monensin (19) increase ruminal production of CLA and concentrations of CLA in milk 
fat. 
The presence of CLA in milk and other foods derived from ruminant animals is 
the result of incomplete biohydrogenation of linoleic acid to stearic acid in the rumen 
(18). Significant quantities of the CLA intermediate then are absorbed, and some 
becomes incorporated into body lipids and milk fat. Therefore, preventing dietary CLA 
from biohydrogenation in the rumen probably will optimize the incorporation of dietary 
CLA into ruminant lipids. Moreover, CLA in animal products also may be derived from 
desaturation of vaccenic acid that is absorbed from the digestive tract (11). 
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Calcium salts of long-chain fatty acids have been utilized extensively as an energy 
source in diets of lactating dairy cows. They remain relatively inert in the rumen under 
normal pH conditions, but they dissociate completely in the acidic conditions of the 
abomasum (31). Calcium salts of fatty acids decrease the inhibition of rumen bacteria by 
free, long-chain fatty acids (30). We hypothesized that the insoluble calcium salt of CLA 
in the rumen would be relatively inert to biohydrogenation so that more CLA would 
become available for absorption from the intestines than when CLA is fed as the free 
acid. A previous study with sheep demonstrated that feeding the calcium salt of CLA 
increases the availability of CLA for absorption from the intestine when compared with 
feeding CLA as the free acid (27). Therefore, the objective of this study was to evaluate 
the effects of feeding CLA as the calcium salt or as the free acid and a linoleic-acid-rich 
oil with or without supplemental CLA on the CLA content of milk. 
MATERIALS AND 1\1ETHODS 
Experimental design. Twelve primaparous and twenty-four multiparous Holstein 
cows in midlactation were used in a completely randomized block design experiment 
with six treatments. Cows (50 to 250 days into lactation) of similar milk production were 
blocked together with the twelve primaparous cows in the first two blocks and the 
twenty-four multiparous cows in the rest four blocks. Within each of the blocks, the six 
cows were assigned randomly to the six diets and each cow was fed her specific diet for 
four weeks. Cows were managed in accordance with guidelines provided by the Iowa 
State University Committee on Animal Care. The six different diets were as follows: 1) 
Control, 2) Control+ 5% soy oil, 3) Control+ 1 % CLA, 4) Control+ 1 % CLA + 4% soy 
oil, 5) Control + 1 % Ca(CLA)2, and 6) Control + 1 % Ca(CLA)2 + 4% soy oil. 
Supplemental fat concentrations are expressed on a dry matter basis. The CLA-containing 
oil was provided by Conlinco Inc. (Detroit Lakes, MN) and contained 67% CLA by 
weight. All diets were fed as total mixed rations. The composition and chemical analyses 
of the control diet are presented in Table 1. The oil containing CLA was added at 1.67% 
and the Ca(CLAh was added at 1.91 % of the diet to provide 1 % CLA in the diet. The dry 
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and palatable Ca(CLA)2 was prepared by combining CaO, water, and the CLA-
containing oil (free fatty acid form) according to the formula: 100.44 g oil+ 18.09 g CaO 
+ 17.79 g H20. Dry matter content was similar among all six diets (about 60%). 
Concerning relative percentages of individual fatty acids in experimental diets (Table 2), 
adding soy oil or CLA increases the percentage of C18:o and decreases the percentage of 
C16:o in total fatty acids. CLA-supplemented diets also had a lower percentage of C1s:1, 
C18:2, and C18:3 compared with the control diet. Supplementing soy oil or CLA as either 
the free acid or the calcium salt both increased the total fatty acid concentration in the 
diet; the soy oil with either form of CLA increased the total fatty acid content even more. 
Sample collection and measurements. Feed samples were collected at weeks 0, 2, 
and 4. One-day milk samples were collected from each cow during weeks 0, 1, 2, 3, and 
4. Rumen fluid was collected from each cow during weeks O and 4. Blood was collected 
during weeks 0, 2, and 4, and plasma was prepared from heparinized blood samples by 
centrifugation at 800xg for 10 min at 4°C. All samples were stored at -20°C until 
analysis. Milk production was recorded. A duplicate set of milk samples were stored at 
4°C until analyzed for fat, protein, and lactose content by infrared analysis (Northeast 
Dairy Herd Improvement Association, Dubuque, IA). Dry matter in feed was quantified 
by drying feed at 65°C for 48 h (1) in a forced-air oven. Nitrogen in feed samples was 
quantified by the Kjeldahl analysis (1). Lipid content of feed was determined by the 
procedure of Bligh and Dyer (5). 
Volatile fatty acids (VFA) in samples of rumen fluid were analyzed by a purge-
and-trap apparatus connected to a gas chromatograph (GC) following the procedure of 
Erwin et al. (17). Percept II and Purge-and-Trap concentrator 3000 (Tekmer-Dohrmann, 
Cincinnati, OH) were used to purge and collect volatiles. Two milliliters of sample were 
placed in a sample vial (40 ml) and purged with helium gas (40 ml/min) for 15 min, and 
volatiles were trapped at 20°C using a Tenax/Silica gel/Charcoal column (Tekmar-
Dohrmann) and desorbed for 2 min at 220°C. The desorbed volatiles were concentrated at 
-100°C using a cryofocusing unit before being thermally desorbed (220°C) and injected 
(30 sec) into a capillary GC column. Ramped oven temperature was used. The initial 
oven temperature was 0°C and was held for 1.50 min. After that, the oven temperature 
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was increased to 20°C at 4 °C per min, increased to 80°C at 10°C per min, increased to 
l 80°C at 20°C per min, and then kept for 4.50 min. The column used was a HP-Wax (7 .5 
m) and HP-5 (30 m, Hewlett-Packard Co., Wilmington, DE) combined column with the 
flow pressure set at 12 psi. A mass selective detector (MSD, HP 5973, Hewlett-Packard 
Co.) was used to determine volatile components. The ionization potential of the MS was 
70 eV, and the scan range was 40-450. Identification of volatiles was achieved by 
comparing mass spectral data of samples with those of the Wiley library (Hewlett-
Packard Co.) and also of the standards. The area of each peak was integrated by using 
ChemStation software (Hewlett-Packard Co.), and total ion counts x 103 was reported as 
an indicator of volatiles generated from rumen fluid samples. 
Lipids of blood plasma were extracted by the procedure of Bligh and Dyer (5). 
The extracted lipids were dissolved in methanol, and fatty acids were quantified by gas-
liquid chromatography (model 5890; Hewlett-Packard, Palo Alto, CA) by using a 
NaOCH3-catalyzed methanolysis procedure (36). Separation of the fatty acid methyl 
esters was performed on a SP-2560 fused silica capillary column (100 m x 0.25 mm i.d. x 
0.2 µm film thickness, Supelco Inc., Bellefonte, PA) by using helium as carrier gas at a 
pressure of 30 psi. Oven temperature was maintaine~ at 70°C for 4 min, then 
programmed at 13°C/min to 175°C, held there for 27 min, programmed at 4°C /min to 
215°C, and finally held there for 31 min. C19:0 was added as an internal standard. 
Identification and quantification of CLA and other long-chain fatty acids were obtained 
by comparison to commercially available reference standards (Nu-Check Prep, Elysian, 
MN). Milk samples were centrifuged at 7000xg for 20 min and the upper layer of milk 
fat was transesterifed to methyl esters using NaOCH3-catalyzed methanolysis. The 
methyl esters of each fatty acid were quantified by gas-liquid chromatography as 
described before. 
Statistical analysis. For analysis of dry matter intake, milk production, blood 
plasma and milk fatty acid composition, data taken during weeks 1 to 4 of the 
experimental period were adjusted by analysis of covariance by using data taken during 
week O as covariables (26). Covariable-adjusted data were analyzed as a completely 
randomized block design with repeated measures by using analysis of variance 
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procedures of SAS (14). The model employed for analysis of variance was: Yijk =µ+Ti 
+ Bj + TBij + W1 + TWii + Eijk where YijkI = dependent variable for cow k on treatment i 
and block j during time 1, µ = population mean, Ti = treatment effect, Bj = block effect, 
TBij = interaction of block and treatment, W1 = time effect, TWil = interaction of 
treatment and time, and EikG)I = residual error. Significance was declared at P < 0.05. 
Tukey's multiple comparison method was used for all pairwise comparisons among the 
six diets. 
RESULTS AND DISCUSSION 
Feed intake and milk yield. Mean dry matter intake, milk yield, and milk 
composition data are presented in Table 3. No significant treatment x week interaction 
was observed for dry matter intake and milk production variables. Neither CLA nor soy 
oil supplements had significant effects on daily dry matter intake, which averaged 20.4 
kg/d. The intake of the fat-supplemented diets was slightly less, which resulted in similar 
intakes of metabolizable energy (data not shown). Also, supplementing the diet with soy 
oil or CLA did not decrease milk yield. 
Dietary treatments had no effect on milk protein and lactose contents of milk, 
which is consistent with results of Chouinard et al. (9). In contrast, CLA supplements 
resulted in a dramatic decrease in milk fat synthesis, which also was achieved by addition 
of soy oil. Addition of soy oil to the CLA-containing diet caused milk fat depression that 
was greater than that caused by CLA alone when fed as either the free acid or as the 
calcium salt. 
A previous study by Lawless et al. (37) showed that feeding cows a diet 
supplemented with full-fat soybeans at 3.1 kg/d did not affect yields of milk protein or 
lactose, which is consistent with results from our study when supplementing soy oil to the 
control diet. In the experiment by Chouinard et al. (9), CLA supplemented from 50 to 100 
g/d also did not affect yield of milk and milk protein. Other researchers observed 
decreases in milk protein percentages when supplementing diets with fat (10, 22), 
especially with fats rich in unsaturated fatty acids (20). The adverse effect of dietary fat 
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on microbial fermentation and microbial protein yield in the rumen may decrease the 
available protein supply for cows (29). Yet, it is not necessarily true that unsaturation of 
the fat supplement will affect milk protein percentages (15, 46), nor does changes in milk 
protein concentration necessarily lead to a change in total protein produced when the 
milk yield is related inversely to milk protein concentration (16). The latter observation 
suggests that the depression of milk protein caused by unsaturated fat supplementation 
results from a dilution effect. A study by Dhiman et al. (15) suggested that the negative 
effect of unsaturated fat on milk protein content would not occur when the dietary protein 
is adequate for the production level of dairy cows. 
It is generally known that ingested fatty acids, especially if they are unsaturated, 
inhibit microbial growth ( 45). The toxicity of those fatty acids has been explained by 
their great surface activity and consequent effects in changing permeability of bacterial 
cell membranes (12). Supplementing calcium salts of fatty acids minimizes the 
detrimental effects of dietary fat on ruminal fermentation (6). Previous studies by 
Murphy et al. ( 42) showed that, although increasing dietary unsaturated fat led to a 
decrease in rumen fiber digestion, there was only a small effect on total cellulose and 
hemicellulose digestion because of compensatory hindgut fermentation of dietary fibers. 
Thus, no significant difference in milk lactose concentration would be expected. Our 
study also showed no effect on milk lactose percentage and yield when supplementing 
the diet with soy oil or CLA as the free acid or as the calcium salt, which is consistent 
with observations by Dhiman et al. (15) when feeding cows a diet supplemented with 4% 
soy oil. Perhaps the increased dietary fat may have resulted in more ruminal 
hydrogenation of fatty acids, and thus the effect of unsaturated fatty acids on fiber 
digestion was minimized. 
In our study, diets supplemented with soy oil, with CLA as the free acid or as the 
calcium salt, or with a combination of soy oil and CLA in either form caused a decrease 
in milk fat content and consequently a decrease in total milk fat production. Milk fat 
depression has long been known to be caused by feeding diets containing significant 
concentrations of fats rich in polyunsaturated fatty acids (PUFA), like soy bean oil (26, 
37). Hippen et al. (26) pointed out in their study that the decreased milk fat production 
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when feeding fats rich in PUPA compared with fats rich in saturated fatty acids is partly 
attributable to negative effects of the unsaturated fats on dry matter intake and 
subsequently lower fiber intake. Yet, this effect on dry matter intake was not observed in 
our study. Chouinard et al. (9) observed a milk fat decrease in cows given a daily 
abomasal infusion of CLA of 0.14 to 0.5% of the diet on a dry matter basis. Dhiman et al. 
(15) also observed the milk fat depression in cows when supplementing diets with 3% to 
4% soy oil of dietary dry matter, but not when soy oil was supplemented at 1 % to 2% of 
dry matter, which suggested that the hydrogenation ability of rumen microorganism may 
be exceeded when given large amounts of supplemental fat rich in unsaturated 18-carbon 
fatty acids. Typically, in conditions such as high concentrate diets, supplementation of 
rumen-active fats, and diets with small particle size forage, which lead to decreases in 
milk fat yield, there will be fat accretion in adipose tissue while mammary synthesis of 
milk fat is decreased (51). This response is not likely to be the case in CLA-induced milk 
fat reduction. The effect of feeding CLA on fat deposition in adipose tissue of our cows 
was not measured. Dhiman et al. (13) suggested that the decrease of milk fat content may 
result from the increased dietary supply of C18:2 because of the increased vaccenic acid in 
milk that is derived from ruminal biohydrogenation. 
Rumen VFA. Concentrations of total and individual VFA were determined to 
evaluate the effect of CLA, soy oil, and of combination of the two oils on rumen 
fermentation. Concentrations of total VFA in the rumen were decreased slightly but not 
significantly (P > 0.05 for every pairwise comparison) by supplementing the diet with 
CLA or soy oil or both (Table 4 ). Feeding CLA as the free acid or as the calcium salt had 
similar effects. Also, no significant differences (P > 0.05) for individual VFA percentages 
as well as for the acetate to propionate ratio were observed among the experimental diets, 
suggesting that the fat supplements had no effects on rumen fermentation. The lack of an 
effect of dietary fat at these low concentratii:ms on rumen fermentation is consistent with 
reports by other authors, where dietary fat has little effect on rumen VF A content and the 
acetate to propionate ratio (22, 42). 
Plasma. Dietary fat supplementation, either as soy oil or CLA, resulted in an 
overall increase in total plasma fatty acid concentrations (Table 5), which agrees with the 
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earlier study of dairy cows by Hippen et al. (26). Of the individual fatty acids, 
concentrations of C16:o, C18:1, C18:2, and Cis:3 were higher in the fat-supplemented groups. 
The increase in C1s:o concentration was not significant (P > 0.05) because of large 
variation among cows. 
Consistent with results from Hippen et al. (26), who fed cows a highly 
unsaturated fat-supplemented diet, the increased concentration of the saturated C16:o and 
C1s:o in the plasma of cows caused by supplementing unsaturated fatty acids suggests a 
cooperativity between absorption of saturated and unsaturated fatty acids (44). To the 
contrary, a decrease in C16:0, C1s:o, and C1s:2 concentrations in plasma was reported by 
Wonsil et al. (53) together with diminished total fatty acid absorption when feeding soy 
oil to lactating cows. 
The increase of C18:1 concentrations in plasma by feeding fats rich in unsaturated 
fatty acids suggests that dietary supplementation increased the rate of biohydrogenation 
in the rumen (21, 53). According to a study by Bickerstaffe et al. (4), 90% of dietary 18:2 
is hydrogenated in the rumen; therefore an increase in C1s:2 concentrations in plasma by 
dietary fat supplementation probably can not be explained merely by greater intestinal 
absorption of unsaturated fatty acids, but probably by a slower turnover rate. A positive 
relationship was found between the change in plasma C18:2 and the content of 
phospholipids, cholesterol, and cholesterol esters by feeding a highly unsaturated fat (49, 
50). Hippen et al. (26) suggests a "spillage" of fatty acids from lipoprotein particles when 
a high fat diet rich in unsaturated fatty acids is fed. Supplementing unsaturated fat may 
lead to a greater release of C18:2 from tissues to blood or a decreased uptake of fatty acids 
by tissues through lipoprotein lipase (LPL) action (24). In another study, when PUPA 
was fed to steers at 10% of dietary dry matter, activities of adipose LPL increased and 
adipose tissue uptake of C18:2 increased (7). The concentration of CLA in the plasma was 
not detected. 
Milk fatty acids. There was no significant treatment x week interaction for milk 
fatty acids and therefore weekly means of milk fatty acids during sampling weeks are 
presented in Table 6. Supplementing the diet with soy oil and/or CLA as the free acid or 
the calcium salt decreased the content of short- and medium-chain fatty acids (C4:0-C14:o) 
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as well as C16:o in the milk fat compared with the control diet, and the extent of the 
decrease was related positively to the amount of total fat in the diet. The proportions of 
C1s:o, C1s:1, and C1s:2 were increased. The changes in those 18-carbon fatty acids in milk 
are in accordance with the change of those fatty acids in plasma. Grummer (23) observed 
an increase in the proportion of C1s:1 in milk fat through feeding dairy cows lipids rich in 
unsaturated 18-carbon fatty acids. There was a decrease in the C18:3 proportion in milk fat 
when 5% soy oil or 4% soy oil + 1 % CLA as the free acid was supplemented, which is 
consistent with results by Dhiman et al. (15) when soy oil was fed at 4% of dry matter, 
whereas no change in the C18:3 proportion was observed when supplementing 1 % CLA as 
the free acid or 4% soy oil + 1 % CLA as the calcium salt. An increase in the proportion 
of Cis:3 in milk fat was observed when 1 % CLA was supplemented as the calcium salt. 
The ratios of C16:0 to C16:1 and C1s:o to C1s:1 were decreased by soy oil supplementation, 
whereas CLA feeding has no significant effect on these ratios as well as on the ratio of 
C14:o to C14:I• An increase in ratio of C14:0 to C14:1 was observed only when feeding cows 
4% soy oil plus 1 % CLA as the calcium salt in comparison to control. In contrast, 
Chouinard et al. (9) observed an increase in the ratio of C14:o to C14:I, C16:o to C16:I, and 
C1s:o to C18:1 by abomasal infusion of CLA and suggested that CLA decreased the ~-9 
desaturase activity especially in the mammary tissues. Also, a decrease in mice hepatic~-
9 desaturase mRNA expression by feeding CLA was observed by Lee et al. (39). 
Compared with feeding of CLA as in our study, the higher amount of CLA absorbed by 
cows to inhibit ~-9 desaturase expression observed by Chouinard et al. (9) suggests that 
abomasal infusion of CLA is a more efficient way to increase availability of CLA for 
absorption by dairy cows than feeding of CLA because of the avoidance of tremendous 
rumen biohydrogenation of CLA. 
With respect to CLA concentration of milk, adding CLA as the free acid to the 
diet increased the CLA weight percentage in milk fat, and feeding CLA as the calcium 
salt increased it even more (P < 0.1). Adding 5% soy oil to the diet had a greater effect on 
increasing CLA content than did simply adding CLA in either form, which is consistent 
with the results of Dhiman et al. (15). There is no significant difference between feeding 
5% soy oil and feeding 4% soy oil + 1 % CLA as the free acid or the calcium salt. The 4% 
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soy oil + 1 % calcium salt of CLA diet resulted in the greatest CLA concentration (P < 0.1 
for comparison between 5% soy oil and 4% soy oil + 1 % CLA as the calcium salt) in 
milk at 1.41 g per 100 g milk fat. 
Dietary supplementation of CLA as the free acid increased the ratio of PUF A to 
saturated fatty acids (PIS) and the ratio of monounsaturated fatty acids to saturated fatty 
acids (MIS). Feeding CLA as the calcium salt increased the PIS even more. Soy oil 
addition increased both the PIS and MIS of milk. Addition of CLA to the soy oil diet as 
the calcium salt but not as the free acid increased the PIS additionally (P < 0.05). 
To relate the changes in fatty acid composition to human health, an index of 
atherosclerosis and an index of thrombogenicity were calculated (52). These data are in 
Table 6. The addition of soy oil and/or CLA to the diets decreased the index of 
atherosclerosis (P < 0.05). The decrease caused by adding CLA in either form was 
similar, but is was not as great as for the diets containing soy oil. These data support the 
anti-atherogenesis effect of dietary CLA as proposed by Lee et al. (38) and Nicolosi and 
Laitinen (43). The same relationship of diet to the index of thrombogenecity as to the 
index of atherosclerosis was observed. 
The decrease of C4:o-C14:o and C16:o concentrations in milk caused by CLA or soy 
oil supplementation is consistent with the decrease in other reports (9, 26). Because 
almost all milk C4:o-C14:o and about half of C16:o is synthesized de novo by the mammary 
epithelial cells, these changes suggest that the mechanism of milk fat depression caused 
by CLA involves inhibition of de novo fatty acid synthesis. According to rumen VFA 
concentration of those cows, CLA- or soy oil- supplemented diets lead to a slightly 
decreased acetate concentration (P > 0.05) in comparison to the basal diet. The inhibition 
of the de novo synthesis of fatty acids by CLA can not be attributed simply to the 
shortage of substrate for fatty acid synthesis, because addition of CLA to the diet did not 
change VFA concentrations in the rumen (Table 4). The possible mechanism of 
inhibition of fatty acid synthesis needs further study, but it is probably related to 
inhibition of acetyl-CoA carboxylase because long-chain fatty acids inhibit activity of 
this enzyme (41) and expression of its gene (54). However, because the full complement 
of fatty acids is required for formation of triacylglycerol, the inhibition sites of milk fat 
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secretion of CLA could be anywhere within the pathway of fatty acid esterification, 
packaging of milk fat, or secretion of milk fat (9). 
Soy oil has a large proportion of C18:2 (51 wt%), the precursor of CLA, and has 
been an efficient dietary supplement to increase the CLA content in milk (15). Kelly et al. 
(34) showed that CLA concentration in milk fat could be increased by dietary PUFA 
supplementation, especially oils rich in linoleic acid. Results from our study indicate that 
feeding soy oil at 5% of the diet to lactating cows is a more effective method to increase 
CLA concentrations in milk than is feeding CLA as a free acid or a calcium salt at a 
concentration of 1 % of the diet. This conclusion is probably true because of extensive 
biohydrogenation in the rumen (27). Supplemental CLA is highly vulnerable to 
hydrogenation because of its conjugated double bonds, and feeding equal amount of C18:2 
thus results in more CLA being transferred to the intestine (35). Moreover, Dhiman et al. 
(15) suggested that the biohydrogenation ability of rumen microorganisms could be 
exceeded when larger amounts of Cis:2 are presented to the rumen. In their study, feeding 
soy oil at 3% to 4% of the dietary dry matter resulted in higher CLA proportions in milk 
fat than did feeding the control diet, whereas supplementing the diet with soy oil at 1 % to 
2% did not affect the CLA proportion in milk, indicating that the greater CLA proportion 
in milk fat when feeding higher amounts of soy oil may result from increased escape of 
CLA to the intestine from incomplete biohydrogenation in rumen. 
We detected two major peaks of CLA after gas chromatography. According to 
Kramer et al. (36), the first CLA peak consists mainly of the c9, tll-CLA isomer 
(together with small proportions of other isomers like t9, cll-CLA), and the second peak 
consists of mainly tlO, c12-CLA isomer (together with small proportion of other isomers 
like c9, cll-CLA). As to the effect of dietary fat supplementation on distribution of CLA 
isomers in milk fat, an increase in the proportion of c9, tll- CLA isomers was observed 
when supplementing diets with 5% soy oil or 4% soy oil plus 1 % CLA as the free acid. 
This change was expected because the c9, tll-CLA isomer is derived directly from C18:2 
isomerization during ruminal biohydrogenation (35), and it is the major CLA isomer 
found in animal-derived foods. This isomer also is considered the most biologically 
active one (25). The percentages of tlO, c12-CLA and c9, tl 1-CLA in the dietary CLA oil 
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is 42% and 55%, respectively. The higher proportion of tl0, cl2-CLA isomer and lower 
proportion of c9, tll-CLA isomer in milk of cows fed 1 % CLA as the calcium salt or 4% 
soy oil + 1 % CLA as the calcium salt compared with milk of cows fed control diet or 
supplementing soy oil or CLA as the free acid or both suggested the protective effect of 
calcium salt on ruminal biohydrogenation of dietary CLA. 
Daily yields of all milk fatty acids containing fewer than 16 carbons were 
decreased by supplementing control diets with soy oil or CLA or both (Table 7). The 
decreased de novo synthesis is consistent with result of Hippen et al. (26). Because milk 
C4:o can be supplied by pathways not involving acetyl-CoA carboxylase, the decrease in 
the incorporation of C4:o into the milk fat suggests that the milk fat depression may be 
partly attributable to decreased supply of substrates in addition to the depression of 
acetyl-CoA carboxylase. Daily output of C18:o in milk fat was decreased by 
supplementing 4% soy oil+ 1 % CLA as calcium salt, whereas the difference between the 
other four supplementation and the control were not significant (P > 0.05). Consistent 
with the observation by Hippen et al. (26), daily incorporation of C18:1 and C18:2 was not 
affected by the dietary treatments. Daily yield of milk CLA was increased by 
supplementing 5% soy oil, 4% soy oil + 1 % CLA as the free acid or as the calcium salt. 
To maximizing CLA content of milk and daily incorporation of CLA into milk, an 
ideal supplement would seem to be either C18:2 rich oils or a combination of C18:2 rich oils 
and CLA as the free acid or as the calcium salt. We base this suggestion on our results of 
feeding cows a soy oil-supplemented diet with or without CLA. And it seemed more 
economically practical to feed soy oil to cows than feeding expensive CLA to increase 
the content and yield of CLA in milk. 
CONCLUSIONS 
Supplementing a control diet with 5% soy oil, 1 % CLA as a free acid, 1 % CLA as 
' calcium salt, 4% soy oil+ 1 % CLA as a free acid, or 4% soy oil +1 % CLA as calcium 
salt (1) had no effect on dry matter intake, rumen VFA concentrations, milk yield, milk 
protein and lactose concentrations and yields, (2) decreased milk fat concentration and fat 
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yield principally by decreasing short- and medium- chain fatty acid synthesis. Dietary 
supplementation of 5% soy oil or 4% soy oil + 1 % CLA as the free acid or the calcium 
salt increased the concentration of total fatty acids in plasma. Dietary supplement of 1 % 
CLA as the free acid or the calcium salt increased CLA content in milk, whereas feeding 
5% soy oil or 4% soy oil+ 1 % CLA as the free acid or the calcium salt of CLA caused a 
greater CLA content in milk and increased daily yield of CLA in milk. In conclusion, it 
seems more economically practical to feed soy oil to cows than to feed expensive CLA to 
increase CLA content of milk. 
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Table 1. Ingredients and chemical composition of the control diet1 
Composition Concentration 
---------------------------------------(% of DM)-----------------------------------------
Ingredient 
Alfalfa haylage 7.4 
Corn silage 31.3 
Alfalfa hay 9.6 
High moisture corn 24.2 
Corn gluten feed 13.0 
Soybenmeal 11.0 
Vitamin-mineral supplement2 3.5 
Chemical analysis 
Crude protein 16.8 
ADF2 17.9 
NDF3 30.5 
Lipid 3.0 
Ash 6.9 
DM on an as-fed basis= 62.4%. 
2 Contained 15.3% NaHCO3, 4.3% MgO, 17.3% Ca3(PO4)z, 28.9% CaCO3, 3.1% vitamin A, D, and E 
premix, 0.305% vitamin A, 2.9% vitamin E premix, 1.8% dairy trace minerals mix. The mineral 
supplement was prepared by The Heart of Iowa Coop., Gilbert, Iowa. 
3 Acid detergent fiber. 
4 Neutral detergent fiber. 
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Table 2. Fatty acids composition (?f the experimental diets. 
Diet1 
Fatty acid Control so CLA SO+CLA Ca(CLA)z SO+Ca(CLA)z 
------------------------------g/ 1 OOg fatty acids------------------------------
C14,o 0.17 0.20 0.22 0.19 0.26 0.12 
C16:o 17.00 13.78 11.18 12.04 11.02 12.34 
C16:l 0.21 0.15 0.32 0.16 0.24 0.21 
Crs,o 2.32 3.16 4.02 3.32 3.89 3.22 
C1s,1 20.29 19.74 15.06 17.01 14.87 16.67 
C1s,2 51.30 50.67 32.80 35.85 33.26 35.74 
C1s,3 5.92 7.42 4.03 5.66 4.55 5.57 
CLA ND4 0.85 27.40 12.45 26.60 13.02 
c9,tll-2 ND4 0.16 10.71 4.97 10.43 5.30 
tl0,cl2-3 ND4 0.46 13.09 5.88 12.95 5.95 
C20,o 0.31 0.28 0.21 0.33 0.23 0.20 
Total FA,% ofDM 1.80 6.80 3.50 7.40 3.40 7.20 
1 Control= control diet, SO = control diet+ 5% soy oil, CLA = control diet+ 1 % CLA as free acid, SO + 
CLA = control diet+ 4% soy oil + 1 % CLA as free acid, Ca(CLA)z = control diet+ 1 % CLA as calcium 
salt, SO + Ca(CLA)2 = control diet+ 4% soy oil+ 1 % CLA as calcium salt 
2 CLA isomers, mainly c9,tl 1-CLA, with small proportion of other isomers like t9,cl 1-CLA. 
3 CLA isomers, mainly tlO,cl l-CLA, with small proportion of other isomers like c9,cll-CLA. 
4Not detected. 
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Table 3. Effect of dietary treatment on dry matter intake, milk yield, and milk 
composition in dairy cows 
Diet1 
Variable Control so CLA SO+CLA Ca(CLAh SO+Ca(CLA)2 SEZ 
DMI,kg/d 21.53 19.75 20.72 20.09 21.48 18.92 0.95 
Milk yield, kg/d 30.26 28.79 29.69 29.09 29.87 28.74 0.39 
Protein, g/100 g milk 3.18 3.06 2.99 3.15 3.09 3.11 0.07 
Protein yield, kg/d 1.05 0.97 0.96 1.00 1.02 0.97 0.02 
Lactose, g/100 g milk 4.80 4.74 4.79 4.87 4.76 4.61 0.09 
Lactose yield, kg/d 1.53 1.47 1.56 1.51 1.57 1.49 0.03 
Fat, g/100 g milk 3.53" 2.73b 2.62b 2.17b 2.62b 2.22b 0.13 
Fat yield, kg/d 1.12" 0.85b 0.87b 0.64c 0.87b 0.66c 0.04 
1 Control= control diet, SO= control diet+ 5% soy oil, CLA = control diet+ 1 % CLA as free acid, SO+ 
: 
CLA = control diet+ 4% soy oil + 1 % CLA as free acid, Ca(CLAh = control diet+ 1 % CLA as calcium 
salt, SO + Ca(CLAh = control diet+ 4% soy oil + 1 % CLA as calcium salt. 
2 Standard error of the mean. 
a,b,cMeans on the same row with different superscripts differ (P < 0.05). 
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Table 4. Rumen volatile fatty acid~1 
Diet2 
Item Control so CLA SO+CLA Ca(CLAh SO+Ca(CLA)2 SE3 
Total VFA (mmol/L) 85.0 64.3 64.8 71.2 64.5 71.0 4.9 
-------- · -----------------------------mo 1/ 100 mol---------------------------------
Acetic 63.6 61.2 62.7 62.1 64.8 62.1 1.1 
Propionic 18.1 20.2 I 19.4 20.7 17.9 21.5 1.1 
Isobutyric 1.1 1.2 0.9 1.1 1.0 1.1 0.1 
Butyric 14.0 13.9 13.7 13.l 13.3 12.0 0.6 
Isovaleric 2.0 1.8 1.9 1.7 1.8 1.6 0.2 
Valerie 1.3 1.7 1.4 1.3 1.3 1.7 0.2 
Acetate: propionate 3.6 3.2 3.3 3.1 3.7 3.0 0.2 
Samples were collected 4hr after morning feeding. 
2 Control = control diet, SO = control diet+ 5 % soy oil, CLA = control diet + 1 % CLA as free acid, SO + 
I 
CLA = control diet+ 4% soy oil + 1 % CLA as free acid, Ca(CLA)z = control diet+ 1 % CLA as calcium 
salt, SO + Ca(CLAh = control diet+ 4% soy oil + 1 % CLA as calcium salt. 
3 Standard error of the mean. 
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Table 5. Fatty acid concentrations in blood plasma of cow fed different diets 
Diet1 
Fatty acid Control so CLA SO+CLA Ca(CLA)z SO+Ca(CLA)2 SE2 
--------------------------------mg! 100 ml-----------------------------------------
C14,o 0.75 0.93 1.76 1.14 1.61 1.03 0.28 
C14,1 1.05 1.07 1.61 1.39 1.68 1.13 0.20 
C1s,o 0.68 0.63 0.80 0.76 1.07 0.73 0.10 
C16:o 11.08a 14.44ab 16.36b 16.98b 14.06ab 16.69b 1.11 
C16:l 1.74 2.17 1.98 2.26 2.09 2.27 0.22 
C11,o 1.07 1.56 1.59 1.69 1.26 1.01 0.15 
C11,1 0.49 0.36 · 0.37 0.51 0.39 0.49 0.05 
C1s,o 18.27 24.05 23.07 25.25 25.09 25.69 1.82 
C1s:1 10.24a 21.28bcd 16.31 abc 25.25d 12.37ab 22.34cd 1.67 
C1s:2 46.30a 66.83abc 65.09abc 78.01° 56.76ab 70.28bc 4.86 
Cis:3 2.89a 3.89abc : 3.46ab 4.47° 3_55abc 3.91 be 0.23 
Total FA 103.89a 146.52b 142.28ab 170.llb 138.48ab 155.43 b 8.97 
1 Control= control diet, SO = control diet+ 5% soy oil, CLA = control diet+ 1 % CLA as free acid, SO + 
CLA = control diet+ 4% soy oil + 1 % CLA as free acid, Ca(CLA)z = control diet+ 1 % CLA as calcium 
salt, SO + Ca(CLA)2 = Control diet+ 4% soy oil + 1 % CLA as calcium salt. 
2 Standard error of the mean. 
a, b, c, d Means on the same row with differe~t superscripts differ (P < 0.05). 
70 
Table 6. Effect of dietary treatments on the profile of milk fatty acid. 
Diet1 
Fatty acid Control so CLA SO+CLA Ca(CLA)z SO+Ca(CLA)2 SE2 
g/~00g fatty acids 
C4,o 2.75a 1.99b 2.37ab 2.19b 2.33ab 2.llb 0.12 
C6,o 2.50a 1.52c 2.17ab l.62bc 1.98 b 1.52c 0.10 
Cs,o 1.52a 0.81c 1,29ab a.soc 1.13b 0.76c 0.07 
C10:o 3.09a 1.63c 2.52b 1,55c 2.48 b 1,57c 0.10 
C12:o 3.08a 1.90c 2.79b 1,72c 2.72b 1,72c 0.07 
C14:o 10.58a 7.70b 9.89a 7.67b 9.88a 7.96b 0.17 
C14:1 1.27a 0.94b 1.18a 0.99b 1.1r 0.91b 0.04 
C1s,o 1.13a 0.74c 0.96b 0.74c 0.93b 0.78c 0.04 
C1s:1 0.26abc 0.25abc 0.28ab o.20ac 0.33b 0.18c 0.03 
C16,o 32.43a 23.71c 29.18b 24.28c 28.27b 24.79c 0.47 
C16:1 2.0lab 2.33a 1.69bc 2.25a 1.62c 2.18a 0.09 
C11,o 0.53a 0.41 be 0.54a 0.39c 0.56a 0.45b 0.01 
C17:1 0.24a 0.16c 0.22ab 0.19bc 0.20bc 0.17c 0.01 
C,s,o 9.62a 11.51 b 11.06b 11.47b 10.84b 11.33b 0.41 
C1s:1 20.98a 33.79c 24.41b 34.lOC 24.82b 33.71c 0.66 
C1s:2 2.90a 3.85c 3.42b 3.83c 4.12c 4.74d 0.10 
C18:3 0.30a 0.24b 0.32a 0.25b 0.40c 0.31a 0.02 
C20,o 0.12 0.11 0.13 0.11 0.13 0.14 0.02 
CLA 0.40a 1.23c 0.72b 1.27c 0.90b 1.41c 0.05 
1 Control= control diet, SO= control diet+ 5% soy oil, CLA = control diet+ 1 % CLA as free acid, SO+ 
CLA = control diet+ 4% soy oil+ 1 % CLA as free acid, Ca(CLA)2 = control diet+ 1 % CLA as calcium 
salt, SO+Ca(CLA)2 = control diet + 4% soy oil + 1 % CLA as calcium salt 
2 Standard error of the mean. 
3 CLA isomers, mainly c9, tll-CLA with small proportion of other isomers like t9, cll-CLA. 
4CLA isomers, mainly tl0, cl2-CLA with small proportion of other isomers like c9, cll-CLA. 
5 PIS = sum of polyunsaturated fatty acids/ sum of saturated fatty acids. 
6 MIS= sum of monounsaturated fatty acids/ sum of saturated fatty acids. 
7 IA= index of antherogenicity. 
8 IT= index of thrombogenicity. 
a,b,c,d,eMeans on the same row with different superscripts differ (P < 0.05). 
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Table 6. (continued) 
Diet1 
Fatty acid Control so CLA SO+CLA Ca(CLAh SO+Ca(CLAh SE2 
Ratio of specific isomer/total CLA 
c9,tll-3 0.66a 0.80b 0.67a 0.77b 0.49c 0.56c 0.02 
t10,cl2-4 0.lla 0.09a 0.07a o.osa 0.19b 0.20b 0.02 
Ratio 
C14,ofC14,1 8.52a 9.16ab 8.65a 8.38a 8.73a 10.57b 0.42 
C16:of C16:l 17.21a 11.28b 18.05a 11.68b 18.27a 12.62 b 0.56 
C18,ofC1s,1 0.49a 0.36b 0.47a 0.34b 0.46a 0.34b 0.ol 
Index 
P!S5 0.06a 0.lld 0.07b 0.10d 0.09c 0.12e 0.003 
M/S6 0.37a 0.74c 0.46b 0.74c 0.47b 0.72c 0.02 
IA7 2.80a 1.37c 2.25b 1.35c 2.17b 1.38c 0.06 
ITS 3.59a 2.02c 3.03b 2.ooc 2.86b 1.99c 0.07 
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Table 7. Effect of dietary treatment on the yields of milk fatty acids. 
Diet1 
Fatty acid Control so CLA SO+CLA Ca(CLA)z SO+Ca(CLA)z SE2 
g/d 
C4,o 31.8a 14.8bcd 15.6b 9.8d 16.4b 10.4cd 1.2 
C6,o 27.9a 17.6b 19.0b 11.6c 19.7b 13.0c 0.9 
Cs,o 17.8a 8.7b 10.7b 4.8c 11.3b 5.8c 0.7 
Crn,o 33.7a 15.SC 22.0bc 7.2d 22.7b 10.lcd 1.6 
C12,o 37.8a 17.7c 21.7bc 8.4d 24.4b 11.2d 1.3 
C14,o 114.9a 71.SC 89.lb 44.9d 89.8b 56.2cd 4.2 
C14,1 15.la 8.2bc 10.lb 5.7c 10.4b 6.lc 0.6 
C1s,o 13.6a 6.5bc 8.3b 3.7d 8.2b 5.0cd 0.5 
C1s,1 3.0a 2.lb 2.4ab 1.2c 2.rb I.le 0.2 
C16,o 371.4a 206.9c 258.lb 138.0d 257.7b 166.7cd 11.5 
C16:l 24.2a 18.Sb 14.3bc 13.6c 14.3bc 14.lc 1.0 
C11,o 5.9a 3.6c 4.8b 2.ld 4.5b 3.0c 0.2 
C11,1 2.6a 1.4cd 2.0b l.ld 1.8bc l.ld 0.1 
C1s,o 103.r 93.iab 99.5ab 85.0ab 98.8ab 79.7b 5.3 
C1s:1 222.3ab 270.0b 217.3ab 250.2b 186.3a 229.0ab 13.5 
C1s,2 28.4 31.3 30.3 32.7 30.0 33.1 1.9 
C1s,3 3.2a 2.lc 2.8ab 2.2bc 3.0a 2.2bc 0.2 
C20,o 1.3a 1.l abc 1.2ab 0.7c 1.2ab 0.9bc 0.1 
CLA 5.la 10.4bc 6.6a 10.2bc 7.8ab 11.2c 0.7 
1 Control= control diet, SO= control diet+ 5% soy oil, CLA = control diet+ 1 % CLA as free acid, SO+ 
CLA = control diet+ 4% soy oil+ 1 % CLA as free acid, Ca(CLA)2 = control diet+ 1 % CLA as calcium 
salt, SO+Ca(CLA)z = control diet + 4% soy oil + 1 % CLA as calcium salt 
2 Standard error of the mean. 
a ,b, c, d Means on the same row with different superscripts differ (P < 0.05). 
' 
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GENERAL CONCLUSIONS 
A study to evaluate effects of dietary sources of CLA as the free acid and as the 
I 
calcium salt on availability of CLA and other long-chain fatty acids for absorption from 
the small intestine of sheep yielded the following conclusions: supplementing basal diet 
with 1 % CLA as the free acid or as the calcium salt (1) had no effect on dry matter and 
crude protein digestibility and ruminal VFA composition, (2) increased lipid digestibility, 
(3) increased the percentage of CLA entering the duodenum that was absorbed. Adding 
1 % CLA as the free acid to the basal diet increased CLA availability for absorption in the 
intestine. And, feeding CLA as a calcium salt decreased its biohydrogenation in the 
rumen. 
In another study to evaluate relative effectiveness of CLA as the free acid and as 
the calcium salt to increase CLA in milk fat, we found that: supplementing the control 
diet with 5% soy oil, 1 % CLA as a free acid, 1 % CLA as calcium salt, 4% soy oil + 1 % 
CLA as a free acid, or 4% soy oil + 1 % CLA as calcium salt (1) had no effect on dry 
matter intake, rumen VF A concentration, milk yield, milk protein and lactose 
concentration and yield, (2) decreased milk fat concentration and fat yield principally by 
decreasing short- and medium- chain fatty acid synthesis. Dietary supplementation of 5% 
soy oil or 4% soy oil + 1 % CLA as the free acid or the calcium salt increased the 
concentration of total fatty acids in plasma. Dietary supplementation of 1 % CLA as the 
free acid or the calcium salt increased CLA content in milk, whereas feeding 5% soy oil 
or 4% soy oil + 1 % CLA as the free acid or the calcium salt caused a greater CLA 
content in milk and increased yield of CLA in milk. 
In conclusion, there exists extensive biohydrogenation of CLA in rumen of sheep 
(rate of biohydrogeation is 96.7% when CLA was fed as the free acid) and feeding CLA 
as calcium salts decreased the rate of biohydrogenation (90.1 % ) in rumen. Concerning 
different methods to increase the concent and yield of CLA in bovine milk, it seemed 
more economically practical to feed soy oil to cows than feeding expensive CLA to 
increase the content and yield of CLA in milk. 
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